Query 018774
Match_columns 350
No_of_seqs 230 out of 2205
Neff 9.9
Searched_HMMs 46136
Date Fri Mar 29 03:55:30 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/018774.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/018774hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 COG0534 NorM Na+-driven multid 100.0 9.5E-42 2.1E-46 321.1 36.3 298 47-347 12-314 (455)
2 PRK10367 DNA-damage-inducible 100.0 8.2E-39 1.8E-43 301.0 36.7 296 48-347 5-305 (441)
3 PRK00187 multidrug efflux prot 100.0 3.3E-38 7.1E-43 299.3 37.8 299 46-347 4-309 (464)
4 PRK10189 MATE family multidrug 100.0 8.9E-37 1.9E-41 289.8 37.9 296 49-347 26-332 (478)
5 PRK09575 vmrA multidrug efflux 100.0 2E-36 4.4E-41 286.5 35.8 298 48-347 8-308 (453)
6 PRK01766 multidrug efflux prot 100.0 8.6E-35 1.9E-39 276.2 37.1 300 45-347 5-312 (456)
7 TIGR00797 matE putative efflux 100.0 3.1E-30 6.7E-35 236.1 35.1 285 60-347 1-289 (342)
8 KOG1347 Uncharacterized membra 100.0 4E-28 8.7E-33 227.4 30.9 300 46-346 22-321 (473)
9 PRK00187 multidrug efflux prot 99.9 2.1E-23 4.5E-28 198.1 28.2 210 44-254 228-444 (464)
10 TIGR01695 mviN integral membra 99.9 8.9E-22 1.9E-26 189.4 35.1 286 54-347 2-297 (502)
11 PRK01766 multidrug efflux prot 99.9 1.3E-22 2.9E-27 192.7 26.2 209 45-254 232-442 (456)
12 COG0534 NorM Na+-driven multid 99.9 2.8E-22 6.1E-27 189.1 27.0 213 43-257 232-446 (455)
13 TIGR02900 spore_V_B stage V sp 99.9 1.2E-21 2.5E-26 188.0 31.3 289 55-347 2-309 (488)
14 PRK10189 MATE family multidrug 99.9 6.2E-22 1.4E-26 188.3 29.0 212 46-258 253-466 (478)
15 PRK09575 vmrA multidrug efflux 99.9 1.5E-21 3.3E-26 185.1 27.4 207 45-254 227-436 (453)
16 PRK15099 O-antigen translocase 99.9 7.5E-21 1.6E-25 178.7 30.2 276 54-340 3-283 (416)
17 TIGR01695 mviN integral membra 99.9 2.1E-20 4.6E-25 179.9 30.0 232 47-287 218-454 (502)
18 PF03023 MVIN: MviN-like prote 99.8 4E-18 8.7E-23 161.0 31.5 205 48-254 194-403 (451)
19 PRK10367 DNA-damage-inducible 99.8 2.5E-18 5.4E-23 162.2 27.4 200 48-254 228-431 (441)
20 COG0728 MviN Uncharacterized m 99.8 1.9E-16 4.1E-21 148.2 35.4 233 49-289 229-466 (518)
21 TIGR02900 spore_V_B stage V sp 99.8 5.2E-18 1.1E-22 162.7 25.9 205 45-254 218-434 (488)
22 PF01554 MatE: MatE; InterPro 99.8 6.3E-20 1.4E-24 149.6 6.1 160 60-220 1-162 (162)
23 PRK15099 O-antigen translocase 99.8 1.6E-16 3.6E-21 149.3 26.2 202 45-253 208-411 (416)
24 PRK10459 colanic acid exporter 99.8 1.9E-15 4.2E-20 145.1 29.4 202 47-254 202-405 (492)
25 PF03023 MVIN: MviN-like prote 99.7 1.3E-14 2.7E-19 137.3 33.1 259 82-347 5-272 (451)
26 COG2244 RfbX Membrane protein 99.7 1.3E-14 2.8E-19 139.0 27.3 187 47-238 208-396 (480)
27 PF01943 Polysacc_synt: Polysa 99.7 1.4E-12 3E-17 115.0 33.8 271 55-341 2-273 (273)
28 COG0728 MviN Uncharacterized m 99.7 1.5E-12 3.2E-17 122.3 34.0 293 51-347 6-306 (518)
29 PRK10459 colanic acid exporter 99.6 9.4E-12 2E-16 119.6 30.0 266 52-339 5-274 (492)
30 TIGR00797 matE putative efflux 99.5 1.5E-12 3.3E-17 119.0 17.8 133 44-177 208-341 (342)
31 COG2244 RfbX Membrane protein 99.5 3.9E-11 8.5E-16 115.0 26.0 281 50-347 4-287 (480)
32 PF13440 Polysacc_synt_3: Poly 99.5 1.4E-09 3.1E-14 94.7 32.7 244 71-338 3-249 (251)
33 KOG1347 Uncharacterized membra 99.1 1.1E-10 2.4E-15 110.1 8.1 206 48-254 243-452 (473)
34 PF07260 ANKH: Progressive ank 99.0 1.6E-06 3.4E-11 75.5 28.3 249 49-305 8-269 (345)
35 PF14667 Polysacc_synt_C: Poly 98.9 3E-07 6.6E-12 73.2 17.8 79 174-254 2-80 (146)
36 PF04506 Rft-1: Rft protein; 98.7 4E-06 8.6E-11 80.7 22.4 203 51-254 252-470 (549)
37 KOG2864 Nuclear division RFT1 98.3 0.00063 1.4E-08 62.3 23.9 199 54-254 241-449 (530)
38 PF01943 Polysacc_synt: Polysa 97.7 0.0003 6.5E-09 61.7 10.4 72 47-119 200-272 (273)
39 PF01554 MatE: MatE; InterPro 97.5 0.00011 2.3E-09 59.3 4.0 67 280-348 1-67 (162)
40 PF13440 Polysacc_synt_3: Poly 96.8 0.012 2.6E-07 50.9 10.1 66 53-118 184-250 (251)
41 COG4267 Predicted membrane pro 94.6 3.5 7.7E-05 37.6 23.9 141 99-254 71-211 (467)
42 PF04506 Rft-1: Rft protein; 92.2 12 0.00027 36.6 20.5 74 271-345 252-328 (549)
43 COG4267 Predicted membrane pro 72.3 82 0.0018 29.2 13.9 95 125-223 319-414 (467)
44 PF07260 ANKH: Progressive ank 63.8 41 0.00088 30.3 7.6 73 268-340 7-80 (345)
45 KOG2234 Predicted UDP-galactos 47.2 2.1E+02 0.0046 26.1 9.5 47 237-283 52-101 (345)
46 PF03904 DUF334: Domain of unk 43.0 1.4E+02 0.0031 25.3 7.2 38 124-161 142-179 (230)
47 PF02487 CLN3: CLN3 protein; 40.4 1.1E+02 0.0023 28.8 6.9 30 43-72 234-263 (402)
48 KOG3097 Predicted membrane pro 39.1 3.1E+02 0.0066 25.3 9.1 63 37-99 14-76 (390)
49 PRK03612 spermidine synthase; 37.5 4E+02 0.0087 26.0 21.9 27 60-86 22-49 (521)
50 KOG2864 Nuclear division RFT1 32.0 4.7E+02 0.01 25.2 22.7 47 52-98 8-55 (530)
51 PF05313 Pox_P21: Poxvirus P21 29.8 2.2E+02 0.0048 23.3 6.1 26 229-254 136-161 (189)
52 TIGR00155 pqiA_fam integral me 29.2 4.9E+02 0.011 24.5 11.0 81 1-81 1-81 (403)
53 KOG0054 Multidrug resistance-a 28.9 8.6E+02 0.019 27.2 19.4 34 307-340 458-491 (1381)
54 COG4304 Uncharacterized protei 28.6 17 0.00038 28.0 -0.2 9 342-350 112-120 (166)
55 PF04505 Dispanin: Interferon- 23.6 2.6E+02 0.0057 19.5 6.3 32 114-145 42-73 (82)
56 PF01102 Glycophorin_A: Glycop 23.5 1.2E+02 0.0026 23.1 3.5 11 230-240 67-77 (122)
57 PF05975 EcsB: Bacterial ABC t 22.4 6.3E+02 0.014 23.4 16.6 35 124-158 89-124 (386)
58 TIGR00927 2A1904 K+-dependent 22.1 1.9E+02 0.0042 30.4 5.5 33 114-146 987-1019(1096)
59 PF01914 MarC: MarC family int 21.3 4.9E+02 0.011 21.7 11.4 63 103-170 13-75 (203)
60 PF02592 DUF165: Uncharacteriz 20.6 4.2E+02 0.009 20.7 12.4 58 229-296 67-124 (145)
No 1
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=100.00 E-value=9.5e-42 Score=321.10 Aligned_cols=298 Identities=20% Similarity=0.239 Sum_probs=277.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchh
Q 018774 47 FWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (350)
Q Consensus 47 ~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~ 126 (350)
..+..|+++++++|++++++.+.+++.+|++++||+|++++|+.++++++..++ ..+..+++.|..+.+||++|+||++
T Consensus 12 ~~~~~k~l~~la~P~i~~~l~~~l~~~vD~~~vG~~~~~alaav~la~~i~~~~-~~~~~gl~~g~~~liaq~~Ga~~~~ 90 (455)
T COG0534 12 FKKILKLLLKLAIPIILGNLLQTLYGLVDTFMVGHLGAEALAAVGLANPIFFLI-IAIFIGLGTGTTVLVAQAIGAGDRK 90 (455)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHHHHHHHHH-HHHHHHHHHhHHHHHHHHHcCCchH
Confidence 567899999999999999999999999999999999999999999999999985 7899999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHH
Q 018774 127 MLGVYMQRSWIVLFICCVLLL-PLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (350)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (350)
++++..+++++++++++++.. +.+++.++++.+++.++|+.+.+.+|+++..++.|+..+...+.+++|+.||+|.+++
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ll~~l~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~m~ 170 (455)
T COG0534 91 KAKRVLGQGLLLALLLGLLLAILLLFFAEPLLRLLGAPAEVLELAAEYLRIILLGAPFALLSFVLSGILRGLGDTKTPMY 170 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCchhHH
Confidence 999999999999999997655 4577999999999998999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhh-cC-CccchHHHHHHHHHHHHHHHHHHHHHhcCC--CcccCCCChHhHHhHHHHHHHHHHH
Q 018774 206 VSLASLLVHLLVTWLFVYK-MQ-LGLIGTAITLSFSWWVLIFGMFGYVACGGC--PRTWTGFSMEAFSDLWEFVKLSVAS 281 (350)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~-~~-~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~p~ 281 (350)
.++++.++|+++||+|+++ ++ +|+.|+++||++++++..++..+++++++. .....+..+.+++.+|+++++|+|.
T Consensus 171 ~~~~~~~lNivln~llI~g~~g~lGv~GAA~AT~ia~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lG~p~ 250 (455)
T COG0534 171 ILLLGNLLNIVLNYLLIFGLFGGLGVAGAALATVIARWIGALLLLIYLLRKKRLLSLFKKKLLKPDRKLLKEILRLGLPI 250 (455)
T ss_pred HHHHHHHHHHHhhHHHHHhccccccchhHHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhccCCCHHHHHHHHHhcccH
Confidence 9999999999999999998 46 999999999999999999999999888752 3333344466788999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCC
Q 018774 282 GVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 282 ~l~~~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
+++...+...+.+.+.+++++|+. ++|+|+++.++.++.++++.|+++|+++++++.++.+|.|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~G~~--~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvG~~~Ga~~~~ 314 (455)
T COG0534 251 FLESLSESLGFLLLTLFVARLGTV--ALAAYGIALRIASFIFMPPFGIAQAVTILVGQNLGAGNYK 314 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHhcChH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 999999999999999999999964 5679999999999999999999999999999999998865
No 2
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=100.00 E-value=8.2e-39 Score=300.95 Aligned_cols=296 Identities=14% Similarity=0.119 Sum_probs=266.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchh
Q 018774 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHL-GDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (350)
Q Consensus 48 ~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~l-g~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~ 126 (350)
+++.|+++++++|.++++++..+++.+|+.++|++ |++++|+.+++.++.+.. ..+..+++.+..+.+||++|+||+|
T Consensus 5 ~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~l~g~~alAa~~l~~~i~~~~-~~~~~~~~~g~~~lvsq~~Ga~~~~ 83 (441)
T PRK10367 5 TSSDKALWRLALPMIFSNITVPLLGLVDTAVIGHLDSPVYLGGVAVGATATSFL-FMLLLFLRMSTTGLTAQAFGAKNPQ 83 (441)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 46789999999999999999999999999999998 677999999999998875 6788999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHH
Q 018774 127 MLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (350)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (350)
++++..++++.+++++++++.+. ..+.++++.+++.|+|+.+.+.+|+++..++.|+..+..++.+++|+.||++.+++
T Consensus 84 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 163 (441)
T PRK10367 84 ALARALVQPLLLALGAGALIALLRTPLIDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANLVLLGWLLGVQYARAPVI 163 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccchHHHH
Confidence 99999999999999999887655 55888888999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc-CCC-cccCCCChHh-HHhHHHHHHHHHHHH
Q 018774 206 VSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG-GCP-RTWTGFSMEA-FSDLWEFVKLSVASG 282 (350)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~-~~~~~~~~~~~~p~~ 282 (350)
.++++.++|++++++++++.++|+.|+++|+.+++++..+...++++++ +.+ .+.+.+ +.+ ++.+|+++++|.|.+
T Consensus 164 ~~ii~~~vni~l~~~lI~~~~lGv~Gaa~At~is~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~il~ig~P~~ 242 (441)
T PRK10367 164 LLVVGNILNIVLDLWLVMGLHMNVQGAALATVIAEYATLLIGLLMVRKVLKLRGISLEML-KTAWRGNFRRLLALNRDIM 242 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCccHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHh-hhhhHHHHHHHHHhCchHH
Confidence 9999999999999999998899999999999999999888777766654 222 111111 122 246899999999999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCC
Q 018774 283 VMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 283 l~~~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
++...+...+.+.+.+++++|+. ++|||+++.++.++.++++.|+++|+++++++.++.+|.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~G~~--alAa~~I~~~i~~~~~~~~~gl~~a~~~lvg~~~Ga~~~~ 305 (441)
T PRK10367 243 LRSLLLQLCFGAITVLGARLGSD--IIAVNAVLMTLLTFTAYALDGFAYAVEAHSGQAYGARDGS 305 (441)
T ss_pred HHHHHHHHHHHHHHHHHHhcCHH--HHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHcCCCHH
Confidence 99999999999999999999964 5779999999999999999999999999999999999876
No 3
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=100.00 E-value=3.3e-38 Score=299.31 Aligned_cols=299 Identities=17% Similarity=0.133 Sum_probs=269.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccch
Q 018774 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (350)
Q Consensus 46 ~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~ 125 (350)
.++++.|+++++++|.+++++...+.+.+|+++++++|++++|+++++.++.+.+ ..+..|++++..+++||++|++|+
T Consensus 4 ~~~~~~k~il~~a~P~~~~~~~~~~~~~~d~~~v~~lg~~alAa~~i~~~i~~~~-~~~~~gl~~~~~~i~aq~~Ga~~~ 82 (464)
T PRK00187 4 PPTTELKAILRLAGPLIASQLAHMLMVFTDTLMMGRLGPEALAGGGLGAASYSFV-SIFCVGVIAAVGTLVAIRHGAGDI 82 (464)
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCCh
Confidence 3467899999999999999999999999999999999999999999999998875 678899999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHH
Q 018774 126 YMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (350)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (350)
|++++..++++.+.++++++..++..+.++++.+++.|+|+.+.+.+|+++..++.|+..+...+++++|+.||++.+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~ev~~~~~~Yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~ 162 (464)
T PRK00187 83 EGATRLAQAGLWLAWLLALVAALLLWNLKPLLLLFGQAPQNVDAAMQFLHLLPFALPGYLSFMALRGFTSALGRAGPVMV 162 (464)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHHH
Confidence 99999999999999999988766666779999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhc----CCccchHHHHHHHHHHHHHHHHHHHHHhcC-C-Cccc-CCCChHhHHhHHHHHHHH
Q 018774 206 VSLASLLVHLLVTWLFVYKM----QLGLIGTAITLSFSWWVLIFGMFGYVACGG-C-PRTW-TGFSMEAFSDLWEFVKLS 278 (350)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~----~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~-~-~~~~-~~~~~~~~~~~~~~~~~~ 278 (350)
.++++.++|+++||+|+++. ++|+.|+++|+.+++....+...+++++++ . +.++ +++.+.+++.+|++++++
T Consensus 163 ~~~~~~~~ni~~~~~lIfg~~g~p~~Gv~Gaalat~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~lg 242 (464)
T PRK00187 163 ISLAGAVANLLLNYALIEGWFGLPKLGLMGIGLVTALVSNGMALALALYIRRHPAYAAYPLRKGLSRPSRAALRELWRLG 242 (464)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCccccccchHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhccccCCCHHHHHHHHHhh
Confidence 99999999999999999864 589999999999998887776666665542 1 1221 222344577899999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCC
Q 018774 279 VASGVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 279 ~p~~l~~~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
+|.+++...+...+.+.+.+++++|+. ++|+++++.++..+.++++.|+++|.++++++.++.+|.|
T Consensus 243 ~P~~~~~~~~~~~~~i~~~~i~~~G~~--alAa~~i~~~i~~l~~~~~~gi~~a~~~lvgq~~Ga~~~~ 309 (464)
T PRK00187 243 LPIGGTYAVEVGLFTFAALCMGALGST--QLAAHQIALQIVSVAFMVPVGLSYAVTMRVGQHYGAGRLL 309 (464)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHcCHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHH
Confidence 999999999999999999999999975 5669999999999999999999999999999999999875
No 4
>PRK10189 MATE family multidrug exporter; Provisional
Probab=100.00 E-value=8.9e-37 Score=289.82 Aligned_cols=296 Identities=13% Similarity=0.172 Sum_probs=265.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhH
Q 018774 49 IESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYML 128 (350)
Q Consensus 49 ~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~ 128 (350)
+..|+++++++|.++++++..+.+.+|+.+++++|++++|+++++.++..+. ..+..|++++.++++||++|+||+|++
T Consensus 26 ~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~lG~~alAA~~i~~~i~~~~-~~~~~gl~~g~~~lvsq~~Ga~~~~~~ 104 (478)
T PRK10189 26 LFWREITPLAVPIFIENLCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVI-MAFFAAIDLGTTVVVAFSLGKRDRRRA 104 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCCHHHH
Confidence 4589999999999999999999999999999999999999999999998874 788999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcC--CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHH
Q 018774 129 GVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLG--QPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (350)
Q Consensus 129 ~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (350)
++..++++.+++.++++.+++ +.+.++++.++. .|+|+.+.+..|+++..++.|+..+...+.+++|+.||++.+++
T Consensus 105 ~~~~~~~l~~~~~~~~~~~~l~~~~~~~ll~l~~~~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 184 (478)
T PRK10189 105 RAAARQSLVIMTLFAVLLAVLIHFFGEQIIDLVAGDATPEVKALALTYLELTVWSYPAAAITLIGSGALRGAGNTKIPLL 184 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHhCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCchHHhHH
Confidence 999999999999999887655 668889998884 68999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhc----CCccchHHHHHHHHHHHHHHHHHHHHHhc-C--CCcccCC-CChHhHHhHHHHHHH
Q 018774 206 VSLASLLVHLLVTWLFVYKM----QLGLIGTAITLSFSWWVLIFGMFGYVACG-G--CPRTWTG-FSMEAFSDLWEFVKL 277 (350)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~----~~G~~G~a~a~~i~~~~~~~~~~~~~~~~-~--~~~~~~~-~~~~~~~~~~~~~~~ 277 (350)
.++++.++|++++++++++. ++|+.|+++|+.+++++..++..+++.++ + .+.++++ +.+.+++.+|+++++
T Consensus 185 i~~~~~~~ni~l~~~li~g~~~~~~lGv~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~i 264 (478)
T PRK10189 185 INGGMNILNIIISSILIYGLFSWQGLGFVGAGLGLTISRYIGAVAIIWVLMIGFNPALRISLKSYFKPLNFAIIWEVMGI 264 (478)
T ss_pred HHHHHHHHHHHHhHHHHhcCCCCCccchHHHHHHHHHHHHHHHHHHHHHHHhccCccceeeeccccccCCHHHHHHHHHH
Confidence 99999999999999999864 79999999999999999888776665543 2 2222222 122357789999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCC
Q 018774 278 SVASGVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 278 ~~p~~l~~~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
|+|.+++.......+.+.+.+++++|+. ++|||+++.++.++.++++.|+++|+++++++.++.+|.|
T Consensus 265 G~P~~~~~~~~~~~~~~~~~~~~~~G~~--~~Aa~~I~~~i~~~~~~~~~gi~~A~~~lvg~~~Ga~~~~ 332 (478)
T PRK10189 265 GIPASIESVLFNGGKLLTQMFVAGMGTS--VIAGNFIAFSIAALINLPGNALGSASTIITGTRLGKGQIA 332 (478)
T ss_pred hccHHHHHHHHHHHHHHHHHHHHHcCHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 9999999999999888888899999964 5779999999999999999999999999999999998865
No 5
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=100.00 E-value=2e-36 Score=286.51 Aligned_cols=298 Identities=16% Similarity=0.131 Sum_probs=269.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchh
Q 018774 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHL-GDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (350)
Q Consensus 48 ~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~l-g~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~ 126 (350)
++..|+++++++|.+++++...+++.+|+.+++++ |++++++++++.++.++. ..+..+++.+..++++|++|+||+|
T Consensus 8 ~~~~k~i~~l~~P~~~~~l~~~l~~~~d~~~lg~~~g~~~laa~~~~~~~~~~~-~~~~~~~~~g~~~lvsq~~Ga~~~~ 86 (453)
T PRK09575 8 QSIYRTFWRYTIPSIAAMLVNGLYQIVDGIFIGHYVGAEGLAGINMAWPVIGII-LGIGLMVGMGTGSLLSIKRGEGDLE 86 (453)
T ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccccHHHHHHHHHHHHHHHHH-HHHHHHHhccHHHHHHHHhcCCCHH
Confidence 35789999999999999999999999999999995 999999999999998874 6788899999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHH
Q 018774 127 MLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (350)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (350)
++++..++++.++++++++..++ +.+.++++.+++.|++..+.+.+|+++..++.|+..+...+..++|+.|+++.+++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~~~~~~~~~yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~ 166 (453)
T PRK09575 87 KAKRILTTGLLLLLLLGPIVSVILFLFADDFLRAQGAEGRTLELALQYIQVLIWGCLFTLGAIALPFLLRNDESPNLATG 166 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 99999999999999999887655 66899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCCcccC-CCChHhHHhHHHHHHHHHHHHHH
Q 018774 206 VSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWT-GFSMEAFSDLWEFVKLSVASGVM 284 (350)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~p~~l~ 284 (350)
.++++.++|+++++++++.+++|+.|+++|+.+++++..++.++++++++.+.+++ +..+.+++.+|+++++|+|.+++
T Consensus 167 ~~~~~~~~ni~l~~~li~~~~~Gi~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~ig~P~~~~ 246 (453)
T PRK09575 167 LMVIGALINIVLDYLFIGWLDWGLTGAAIATALAQLVVTVLGLGYFFSSRANIRLTLKELRFNWSLAPKIVLLGSSSFFM 246 (453)
T ss_pred HHHHHHHHHHHhhHHHHHhCCchhHHHHHHHHHHHHHHHHHHHHHHHCCCceeEEeeccCCcCHHHHHHHHHhChhHHHH
Confidence 99999999999999999988899999999999999999888777776553333332 12234567889999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCC
Q 018774 285 LCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
...+...+.+.+.+++++|+. .++|++++..++..+.+++..|+++|+++++++.++.+|.|
T Consensus 247 ~~~~~~~~~~~~~~~~~~g~~-~~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvg~~~Ga~~~~ 308 (453)
T PRK09575 247 YLYGSFVVALHNRLFMEYGSA-LTVGAYAIVGYLMVLYYLVAEGIAEGMQPPVSYYFGARQYD 308 (453)
T ss_pred HHHHHHHHHHHHHHHHHhCch-HHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHhcCCChH
Confidence 999999999999999999963 35779999999999999999999999999999999999876
No 6
>PRK01766 multidrug efflux protein; Reviewed
Probab=100.00 E-value=8.6e-35 Score=276.23 Aligned_cols=300 Identities=18% Similarity=0.274 Sum_probs=267.8
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccc
Q 018774 45 RRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKK 124 (350)
Q Consensus 45 ~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~ 124 (350)
+..++.+|+++++++|..++++...+.+.+|+.+++++|++++++++++.++.... ..+..|++.+..|.+||++|++|
T Consensus 5 ~~~~~~~~~il~~~~P~~~~~~~~~~~~~~d~~~i~~~g~~~laa~~~~~~~~~~~-~~~~~g~~~a~~~~vs~~~g~~~ 83 (456)
T PRK01766 5 QKYKSEARQLLALALPILLAQVAQTAMGFVDTVMAGGVSATDLAAVAIGTSIWLPV-ILFGHGLLLALTPIVAQLNGAGR 83 (456)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCC
Confidence 45577899999999999999999999999999999999999999999999987764 67889999999999999999999
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHH
Q 018774 125 YYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVI 203 (350)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~ 203 (350)
++++++..++++.+++.++++++++ +.+.++++.+++.|++..+.+..|+++.+++.++..+...+.+++++.||++.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~yl~i~~~~~~~~~~~~~~~~~l~~~g~~~~~ 163 (456)
T PRK01766 84 RERIAHQVRQGLWLALFLSVLIMLVLYNAVPPILNMMNLEPEVADIAVGYLHALLWGIPAYLLYQVLRSFIDGLGKTKPT 163 (456)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHH
Confidence 9999999999999999999887665 557788999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhc----CCccchHHHHHHHHHHHHHHHHHHHHHhcC-CC--cccCCCChHhHHhHHHHHH
Q 018774 204 AWVSLASLLVHLLVTWLFVYKM----QLGLIGTAITLSFSWWVLIFGMFGYVACGG-CP--RTWTGFSMEAFSDLWEFVK 276 (350)
Q Consensus 204 ~~~~~~~~~~~i~l~~~li~~~----~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~ 276 (350)
++.++++.++|++++++++++. .+|+.|+++|+.+++++..++..+++++++ .+ +.+.++.+.+++.+|++++
T Consensus 164 ~~~~~i~~ivni~l~~~li~~~~~~~~~Gv~Gaa~at~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~ 243 (456)
T PRK01766 164 MVIGFLGLLINIPLNYIFIYGKFGFPELGGVGCGVATAIVYWVMFLAMLIYIKRARRFRDFRLFKGLYKPDWAVIKRLLK 243 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCcccccccHHHHHHHHHHHHHHHHHHHHHhChhhhHHHhhccccCCCHHHHHHHHH
Confidence 9999999999999999998642 589999999999999999888877776552 21 1222223345678999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCC
Q 018774 277 LSVASGVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 277 ~~~p~~l~~~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
+++|.+++...+...+.+.+.+++++|+. ++|++++..++.++.++++.|+++|.++++++.++.+|.|
T Consensus 244 l~~P~~~~~~~~~~~~~~~~~~~~~~G~~--~lAa~~i~~~i~~~~~~~~~gl~~a~~~~v~~~~Ga~~~~ 312 (456)
T PRK01766 244 LGLPIGLAIFFEVSLFAVVTLLVSPLGTV--TVAAHQIALNFSSLLFMLPLSLAMALTIRVGFELGAGRTL 312 (456)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHHcChH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCHH
Confidence 99999999999999999999999999964 4669999999999999999999999999999999888864
No 7
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=100.00 E-value=3.1e-30 Score=236.11 Aligned_cols=285 Identities=24% Similarity=0.413 Sum_probs=254.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhHHHHHHHHHHHH
Q 018774 60 PTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVL 139 (350)
Q Consensus 60 p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 139 (350)
|.+++++...+...+|+.+++++|++++++++++.++..+. ..+..+++++..|.++++.|++|+|+.++..++++.+.
T Consensus 1 p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~a~~i~~~~-~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 79 (342)
T TIGR00797 1 PAILANILQPLLGLVDTAFVGHLGPVDLAAVSLGSSVFMFL-FSILMGLGTATTALVAQAVGAGNYQRLGRQAQQSLLLA 79 (342)
T ss_pred ChHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHhHHHHHHH-HHHHHHHHHhHHHHHHHHHCCCChHHHHHHHHHHHHHH
Confidence 78899999999999999999999999999999999987764 67899999999999999999999999999999999999
Q ss_pred HHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHHHHHHHHHHHHH
Q 018774 140 FICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVT 218 (350)
Q Consensus 140 ~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~ 218 (350)
.+++++.+++ +.+.+++..+++.+++..+++..++++++++.++..+..+..+.+++.||++...+.++++.+++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~~~~~~i~~~ 159 (342)
T TIGR00797 80 LLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMYITLIGNVINIILN 159 (342)
T ss_pred HHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHHHHHHHHHh
Confidence 9999887665 668888888888788888899999999999999999999999999999999999999999999999999
Q ss_pred HHHHh-hcC-CccchHHHHHHHHHHHHHHHHHHHHHhc-CCCcccCCCChHhHHhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 018774 219 WLFVY-KMQ-LGLIGTAITLSFSWWVLIFGMFGYVACG-GCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENWYYRVL 295 (350)
Q Consensus 219 ~~li~-~~~-~G~~G~a~a~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~~~~~~~~~~~~ 295 (350)
+++++ .++ +|+.|+++++.+++++..++..++.+++ +.+.+|++..+.+++.+|++++++.|..+..+...+.+.+.
T Consensus 160 ~~li~~~~g~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~P~~~~~l~~~~~~~~~ 239 (342)
T TIGR00797 160 YILIFGKFGFLGIVGAALATVISYWLMFLLLLYYIKKAKKIGLKWEGLLKPDWEVLKRLLKLGLPIAFRVILESLSFALL 239 (342)
T ss_pred HHHHhcCccccccHHHHHHHHHHHHHHHHHHHHHHHhCCCcccccccccCCCHHHHHHHHHhCchHHHHHHHHHHHHHHH
Confidence 99887 556 8899999999999999888887777654 34333333334556789999999999999999999999999
Q ss_pred HHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCC
Q 018774 296 ILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 296 ~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
+.+++.+|++ ++++|+++.++.++..+++.+++++.++..++.++.+|.|
T Consensus 240 ~~i~~~~g~~--~v~~~~~a~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 289 (342)
T TIGR00797 240 ALLVARLGSI--ALAAHQIALNVESLLFMPAFGFGIAVSILVGQALGAGDPK 289 (342)
T ss_pred HHHHHHcCcH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 9999999864 4669999999999999999999999999999988777755
No 8
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=99.97 E-value=4e-28 Score=227.38 Aligned_cols=300 Identities=39% Similarity=0.659 Sum_probs=284.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccch
Q 018774 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (350)
Q Consensus 46 ~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~ 125 (350)
....+.|++++++.|.++..+.+...+.+++.++||+|+.++++.++++...+...+.+..|+..+..++++|++|++++
T Consensus 22 ~~~~e~k~l~~ia~P~i~~~~~~~~~~~is~~f~GhlG~leLaa~sla~s~~n~~~~s~~~gl~~aletlcgQa~ga~~~ 101 (473)
T KOG1347|consen 22 QLVTESKELARLALPAILTFLAQPLLSLVSTAFAGHLGNLELASVSLANSFANITGVSILLGLQLALDTLCGQAFGAKKF 101 (473)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHhhhccccchHHHHHHHHHHhhcccchHHhhccchhhhcchHhhhccccc
Confidence 34789999999999999999999999999999999999999999999999999878899999999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHH
Q 018774 126 YMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (350)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (350)
+......+++..+....+++....+.+.+++...+++|+++...+..|.++..++.+.......+..+++++++..+..+
T Consensus 102 ~~lg~~lqrs~~~l~~~~~~~~~l~~~~~~il~~lgq~~~i~~~a~~y~~~~ip~~~a~~~~~~l~~~lq~Q~~~~~~~~ 181 (473)
T KOG1347|consen 102 TALGVYLQRSGIVLLVQGLPISLLILNSEPILLLLGQDPDISRDAGSYAFMLIPGLFSYAVSFPLAKFLQAQSITLPLLV 181 (473)
T ss_pred chhhHHHHHHHHHHHHHHHHHHHHHHccHHHHHHhCCChhHHHHHhhhHhhhcchhhhhHHHHHHHHHHHhccCchHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHHHH
Q 018774 206 VSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVML 285 (350)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~~ 285 (350)
+.....++|+++++++++..++|..|++++..++++........+.........|..+..+ ++.++++++.++|.+++.
T Consensus 182 ~~~~~~~lhi~~~~llv~~~~~g~~Gaala~~~s~w~~~~~l~~yi~~~~~~~~w~~~s~~-~~~~~~~~~lai~s~~mi 260 (473)
T KOG1347|consen 182 IGLVALVLHILLTWLLVSKLGLGIKGAALALVASYWLNVRILLLYAVLSGCLAAWSGFSGE-FDSWGPFFALAIPSAVMI 260 (473)
T ss_pred HHHHHHHHHHHHHHHhhhcccCCCccchHHHHHHHHHHHHHHHHHheecCchhhhhhhhHh-hhhHHHHHHHhhcchhee
Confidence 9999999999999999999999999999999999999998888877666667777777766 899999999999999999
Q ss_pred HHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccC
Q 018774 286 CLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDI 346 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~ 346 (350)
.+|+|.+.+..++.+.+++.++++++.++..++....++.+.|++.|+.+-+++-++.++-
T Consensus 261 clE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~~~~~~~~~~~~a~strv~neLGag~p 321 (473)
T KOG1347|consen 261 CLEWWAYEILVLLAGLLGNAKVSLASQSICLEIGGWHLMIPGAFSAAVSTRVSNELGAGKP 321 (473)
T ss_pred HHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHcCCCh
Confidence 9999999999999999999888899999999999999999999999999999998887653
No 9
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=99.93 E-value=2.1e-23 Score=198.15 Aligned_cols=210 Identities=16% Similarity=0.180 Sum_probs=191.3
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhccc
Q 018774 44 TRRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGK 123 (350)
Q Consensus 44 ~~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~ 123 (350)
.+.+++..|+++++++|..++++.......+|+.+++++|++++|+++++.++..+. +.+..|++++.+++++|++|+|
T Consensus 228 ~~~~~~~~k~il~lg~P~~~~~~~~~~~~~i~~~~i~~~G~~alAa~~i~~~i~~l~-~~~~~gi~~a~~~lvgq~~Ga~ 306 (464)
T PRK00187 228 SRPSRAALRELWRLGLPIGGTYAVEVGLFTFAALCMGALGSTQLAAHQIALQIVSVA-FMVPVGLSYAVTMRVGQHYGAG 306 (464)
T ss_pred cCCCHHHHHHHHHhhhhHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHcCC
Confidence 345677899999999999999999999999999999999999999999999998874 7899999999999999999999
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCC--CH---HHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHc
Q 018774 124 KYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQ--PD---DVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQ 197 (350)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~--~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~ 197 (350)
|+|++++..+.++.++++.+++.+++ +.+.+++.+.+.. ++ |+.+.+..|+++.+++.++..++.++.+.+|+.
T Consensus 307 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~~~lrg~ 386 (464)
T PRK00187 307 RLLEARRAGRVGIGFGAVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELFDGTQTIAMGAIRGL 386 (464)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHhhHHHHHHHHhHhcc
Confidence 99999999999999999999877655 6688899988853 43 678889999999999999999999999999999
Q ss_pred cchhHHHHHHHHHH-HHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 198 LKTMVIAWVSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 198 g~~~~~~~~~~~~~-~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
||++.+++.++++. ++++++++++.+.+++|+.|+|+++.+++.+..+.....++++
T Consensus 387 G~~~~~~~~~~~~~~~~~ipl~~ll~~~~~~g~~Gvw~~~~i~~~~~~~~~~~~~~~~ 444 (464)
T PRK00187 387 KDARTTFLIGLACYWLVGAPLAWLLAFTLGWGAVGVWWGLALGLACAAVALTLAFEWK 444 (464)
T ss_pred CccHHHHHHHHHHHHHHHHHHHHHHHhccCCCceeeHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998 9999999999987789999999999999998887776655433
No 10
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=99.92 E-value=8.9e-22 Score=189.45 Aligned_cols=286 Identities=14% Similarity=0.046 Sum_probs=227.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHH-HHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhHhcccchhhHHH
Q 018774 54 LWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLEL-AAISIANTVVVAFNFGLL-LGMASALETLCGQAFGGKKYYMLGV 130 (350)
Q Consensus 54 ~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~-a~~~~a~~l~~~~~~~~~-~g~~~a~~~~~s~~~g~~~~~~~~~ 130 (350)
+.|-+.-..+++++..+.+++|..++++ +|++++ ++++.+.++.+.+..... .|++++..+...++.+++ |+.++
T Consensus 2 ~~k~~~i~~~~~~~~~~~~~~~~~~~a~~lG~~~~~~~~~~~~~i~~~~~~~~~~~g~~~a~i~~~~~~~~~~--~~~~~ 79 (502)
T TIGR01695 2 LLKSTLIVSLGTLFSRITGFVRDAIIASAFGAGLTADAFNVAFVIPNFFRRLFAEGAFNSAFVPVFTKAKKKE--KEARR 79 (502)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChHhhHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHhhh--hHHHH
Confidence 4677888899999999999999999999 899999 899999999875433333 467888777776654332 67777
Q ss_pred HHHHHHHHHHHHHH-HHHH-HHHhhHHHHHhc--CCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHH
Q 018774 131 YMQRSWIVLFICCV-LLLP-LYVFASPVLKLL--GQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWV 206 (350)
Q Consensus 131 ~~~~~~~~~~~~~i-~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 206 (350)
.+.++.......+. +..+ .+++.+++..++ +.+++..+.+..|+++..++.++..+....++++|+.||++.+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 159 (502)
T TIGR01695 80 AFANTVTTLLILSLLLVVLIGIFFAPFVISLLAPGFADETRSLAVSLTRIMFPYLLLISLAAVFGGILNARKRFFIPSFS 159 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeeHHHHHH
Confidence 77776666654443 3344 455778887877 4567777889999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCccchHH--HHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHHH
Q 018774 207 SLASLLVHLLVTWLFVYKMQLGLIGTA--ITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVM 284 (350)
Q Consensus 207 ~~~~~~~~i~l~~~li~~~~~G~~G~a--~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~ 284 (350)
+++..+++++..+++.. ++|..|++ +++++++.+..++.+++.+|++.+ ++...+.+++.+|++++.+.|..+.
T Consensus 160 ~i~~~i~~i~~~~~~~~--~~g~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~k~~l~~~~p~~~~ 235 (502)
T TIGR01695 160 PILFNIGVILSLLFFDW--NYGQYSLALAIGVLIGGVAQLLIQLPFLRKAGFL--LKPRFNFRDPGLKRFLKLFLPTTLG 235 (502)
T ss_pred HHHHHHHHHHHHHHHHc--ccchHHHHHHHHHHHHHHHHHHHHHHHHHHCCCc--ccCcCCCCChhHHHHHHHHHHHHHH
Confidence 99998887765444444 78999998 999999999888877766655322 1111122456789999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHH-HhhHhhhhHhhhhhhhhhcccCC
Q 018774 285 LCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWESQ-ICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~-~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
.........++..+.+.+|+++ +++|+.+.++..+... +..+++++..+.+++.++.+|.|
T Consensus 236 ~~~~~~~~~id~~~~~~~~~~~--v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~ 297 (502)
T TIGR01695 236 SSASQITLLINTALASFLEIGS--VSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWN 297 (502)
T ss_pred HHHHHHHHHHHHHHHhcCCcch--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHH
Confidence 9999999999998877777654 5599999999988764 57899999999999999887754
No 11
>PRK01766 multidrug efflux protein; Reviewed
Probab=99.91 E-value=1.3e-22 Score=192.72 Aligned_cols=209 Identities=20% Similarity=0.200 Sum_probs=193.0
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccc
Q 018774 45 RRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKK 124 (350)
Q Consensus 45 ~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~ 124 (350)
+.+++..|+++++++|..++++.......++..+++++|++++|+++++.++.+.. ..+..|++.+.++.++|++|+||
T Consensus 232 ~~~~~~~k~il~l~~P~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~~~-~~~~~gl~~a~~~~v~~~~Ga~~ 310 (456)
T PRK01766 232 KPDWAVIKRLLKLGLPIGLAIFFEVSLFAVVTLLVSPLGTVTVAAHQIALNFSSLL-FMLPLSLAMALTIRVGFELGAGR 310 (456)
T ss_pred CCCHHHHHHHHHccchHHHHHHHHHHHHHHHHHHHHHcChHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCC
Confidence 34567899999999999999999999999999999999999999999999998875 68899999999999999999999
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHH
Q 018774 125 YYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVI 203 (350)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~ 203 (350)
++++++..+.++.++..++++.+++ +.+.+++..++..|+++.+.+..|+++..+..++..+..+..+++++.||++.+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~~~l~g~g~~~~~ 390 (456)
T PRK01766 311 TLDARQYAYIGLAVGLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQVIGSGALRGYKDTRVI 390 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhchhccCccHHH
Confidence 9999999999999999999887655 668999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHH-HHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 204 AWVSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 204 ~~~~~~~~-~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
++.++++. ++++++.+++.+..++|+.|+|+++.+++++..++..+.+.+.
T Consensus 391 ~~~~~~~~~~~~i~~~~~l~~~~~~G~~G~~~~~~~~~~~~~~~~~~~~~~~ 442 (456)
T PRK01766 391 FFITFIAYWVLGLPLGYILALTDPMGPFGFWIGLIIGLTAAAILLLLRLRKL 442 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHhccCCCceehHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999988 7899999998876689999999999999999998776666544
No 12
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=99.91 E-value=2.8e-22 Score=189.15 Aligned_cols=213 Identities=21% Similarity=0.256 Sum_probs=197.3
Q ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcc
Q 018774 43 LTRRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGG 122 (350)
Q Consensus 43 ~~~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~ 122 (350)
..+.+++..|+++++++|..++++.......+-+.+++++|++.+|+++++.++.++. +.+..|++++.++++++++|+
T Consensus 232 ~~~~~~~~~~~i~~lG~p~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~~~-~~~~~gi~~a~~~lvG~~~Ga 310 (455)
T COG0534 232 LLKPDRKLLKEILRLGLPIFLESLSESLGFLLLTLFVARLGTVALAAYGIALRIASFI-FMPPFGIAQAVTILVGQNLGA 310 (455)
T ss_pred ccCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCC
Confidence 4466779999999999999999999999999999999999999999999999999985 789999999999999999999
Q ss_pred cchhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchh
Q 018774 123 KKYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTM 201 (350)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~ 201 (350)
||+|++++..+.+..++..+++..+++ +.+.+++..+|..|+|+.+.+..++++..+..++.+.+.+..+.+||.||++
T Consensus 311 ~~~~~a~~~~~~~~~~~~~~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~g~lrg~g~~~ 390 (455)
T COG0534 311 GNYKRARRAARLALKLSLLIALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQFVLSGVLRGAGDAK 390 (455)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcH
Confidence 999999999999999999999887655 6699999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHH-HHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCC
Q 018774 202 VIAWVSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCP 257 (350)
Q Consensus 202 ~~~~~~~~~~-~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~ 257 (350)
.+++.++++. ++.+++.+++.+.. +|..|.|++...++.+..+...+++++++++
T Consensus 391 ~~~~~~~~~~~~~~lp~~~~l~~~~-~g~~Gvw~~~~~~~~~~~~~~~~~~~~~~~~ 446 (455)
T COG0534 391 IPFIISLLSYWGFRLPLAYLLGFFF-LGLAGVWIGFPLSLILRAILLLLRLRRGRWR 446 (455)
T ss_pred HHHHHHHHHHHHHHHhHHHHHhhhc-ccchHHHHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 9999999988 66788888888743 9999999999999999999888888776433
No 13
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=99.91 E-value=1.2e-21 Score=187.98 Aligned_cols=289 Identities=11% Similarity=0.106 Sum_probs=228.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhHHHHHH
Q 018774 55 WHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQ 133 (350)
Q Consensus 55 ~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~~~~~~ 133 (350)
.|-+.|..++++...+.+++|+.+++| +|++++|+++.+.++...+......|++++..+.++|..|++|+++.++.++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~~~l~r~Lg~~~~G~~~~~~~~~~~~~~~~~~Gl~~a~~~~is~~~~~~~~~~~~~~~~ 81 (488)
T TIGR02900 2 LKGTFILTIANLITRILGFIFRIVLSRILGAEGVGLYGMAMPIYFLFITLTTGGLPVAISKFVAEASAKNDRKNIKKILK 81 (488)
T ss_pred hHhHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhhHHHHHHHHHHHHHHHHhCCcHHHHHHHHHHHHhccchhhHHHHHH
Confidence 467899999999999999999999999 7999999999999988865444456899999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHHHHHHH
Q 018774 134 RSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLL 212 (350)
Q Consensus 134 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~ 212 (350)
.++.+.++.+++.+++ +.+.+++...+..+++. ..++++.++..++..+......++|+.+|.+.....+.+..+
T Consensus 82 ~~~~l~l~~~~~~~~l~~~~~~~i~~~~~~~~~~----~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~i~~i 157 (488)
T TIGR02900 82 VSLIFTLIWSLIVTAIVFLLSPFIASTLLKDERS----LYSLLVICPAMPFIALSSVLKGYFQGISNMKPPAYIQVIEQI 157 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHcCChhH----HHHHHHHHHHHHHHHHHHHHHHHHhhhccchHhHHHHHHHHH
Confidence 9999999999887655 55677766666555543 246788889999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhh-----cCCccchHHHHHHHHHHHHHHHHHHHHHhc-CCC--cccCCCChHhHHhHHHHHHHHHHHHHH
Q 018774 213 VHLLVTWLFVYK-----MQLGLIGTAITLSFSWWVLIFGMFGYVACG-GCP--RTWTGFSMEAFSDLWEFVKLSVASGVM 284 (350)
Q Consensus 213 ~~i~l~~~li~~-----~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~p~~l~ 284 (350)
++++++..++.. .++|+.|+++++.+++.+..++..++++++ +.+ ..+.+..+.+++.+|++++.++|..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~v~g~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~l~~~~~p~~l~ 237 (488)
T TIGR02900 158 VRISVVALLISAFLPYGLEYAVAGAYLSLVLGELVSLLYLYFFFKRKKSFSIRFPFFDYKSEGKALLFDLFSVSLPLTLS 237 (488)
T ss_pred HHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccCcchHHHHHHHHHHHHHHHHH
Confidence 988776665532 246788889999999988888776665544 212 222222234567899999999999999
Q ss_pred HHHHHHHHHHHHHHHhcC----CCh-hhHHHHH----HHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCC
Q 018774 285 LCLENWYYRVLILMTGNL----QNA-KIAVDAL----SICMSINGWESQICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~----g~~-~~~vaa~----~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
.........+++.++++. |.. ..+.+.+ +++.++..+...+..+++++..+..++.++.+|+|
T Consensus 238 ~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~~~~~~~~~l~~~~~p~~s~~~~~~~~~ 309 (488)
T TIGR02900 238 RFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLTFPAVITSSLSTALVPDISEAMAKKNYS 309 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHHhHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence 999999999888887754 211 1111222 34556667777778899999999999998877754
No 14
>PRK10189 MATE family multidrug exporter; Provisional
Probab=99.91 E-value=6.2e-22 Score=188.32 Aligned_cols=212 Identities=14% Similarity=0.114 Sum_probs=194.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccch
Q 018774 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (350)
Q Consensus 46 ~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~ 125 (350)
.+++.+|++++++.|..++.+...+...+.+.+++++|++++|+++++.++.++. ..+..|++++.+++++|++|++|.
T Consensus 253 ~~~~~~~~il~iG~P~~~~~~~~~~~~~~~~~~~~~~G~~~~Aa~~I~~~i~~~~-~~~~~gi~~A~~~lvg~~~Ga~~~ 331 (478)
T PRK10189 253 LNFAIIWEVMGIGIPASIESVLFNGGKLLTQMFVAGMGTSVIAGNFIAFSIAALI-NLPGNALGSASTIITGTRLGKGQI 331 (478)
T ss_pred CCHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCCCH
Confidence 4578999999999999999999999999999999999999999999999999875 788999999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHH
Q 018774 126 YMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA 204 (350)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 204 (350)
+++|+..+.+..++++.++.++++ +.+.+++..+|..|+|+.+.+..++++.++..++.+.+.+..+.++|.||++.++
T Consensus 332 ~~a~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~g~lrg~G~t~~~~ 411 (478)
T PRK10189 332 AQAERQLRHVFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASWVLPAGLKGARDARYAM 411 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHhhcCCCchHHH
Confidence 999999999999999998887665 6689999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHH-HHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCCc
Q 018774 205 WVSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPR 258 (350)
Q Consensus 205 ~~~~~~~-~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~ 258 (350)
+.++.+. ++.+++.+++.+..++|+.|+|++..+++.+..++..+.+++.++++
T Consensus 412 ~i~~~~~~~v~ip~~~ll~~~~~~g~~Gvw~~~~~~~~~~~~~~~~r~~~~~W~~ 466 (478)
T PRK10189 412 WVSMLGMWGCRVVAGYILGIMLGFGVVGVWMGMFLDWAVRGVLFYWRMVSGRWLW 466 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 9999988 77788888887766899999999999999999888777776665544
No 15
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=99.90 E-value=1.5e-21 Score=185.06 Aligned_cols=207 Identities=14% Similarity=0.207 Sum_probs=188.5
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCh-hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhccc
Q 018774 45 RRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGD-LELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGK 123 (350)
Q Consensus 45 ~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~-~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~ 123 (350)
+.+++..|++++++.|..+++....+...+...+++++|+ +++|+++++.++..+. +.+..|++.+.++.+||++|+|
T Consensus 227 ~~~~~~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~g~~~~lAa~~i~~~i~~~~-~~~~~gi~~a~~~lvg~~~Ga~ 305 (453)
T PRK09575 227 RFNWSLAPKIVLLGSSSFFMYLYGSFVVALHNRLFMEYGSALTVGAYAIVGYLMVLY-YLVAEGIAEGMQPPVSYYFGAR 305 (453)
T ss_pred CcCHHHHHHHHHhChhHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHHHHHHHHH-HHHHHHHHHhhHHHHHHHhcCC
Confidence 4567789999999999999999999999999999999985 6899999999998875 7899999999999999999999
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCC-CHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchh
Q 018774 124 KYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQ-PDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTM 201 (350)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~ 201 (350)
|+|++++..+.++.+++..+++.+++ +.+.+++..++.. |+|+.+.+..|+++.+++.++..+..+..+++|+.||++
T Consensus 306 ~~~~~~~~~~~~l~l~~~~~~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~~~g~~~ 385 (453)
T PRK09575 306 QYDNIKKLLKLAMKVTVLAGIAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFLVLASAYFMAVNQGG 385 (453)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcH
Confidence 99999999999999999999987665 6689999999985 789999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 202 VIAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 202 ~~~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
.++..++...++++++.+++.. .+|+.|+|+++.+++.+..++..+.++++
T Consensus 386 ~~~~~~~~~~~v~ip~~~ll~~--~~G~~Gvw~a~~~~~~~~~~~~~~~~~~~ 436 (453)
T PRK09575 386 KALFISIGNMLIQLPFLFILPK--WLGVDGVWLAMPLSNIALSLVVAPMLWRD 436 (453)
T ss_pred HHHHHHHHhHHHHHHHHHHHHH--HHCcchHhhHHHHHHHHHHHHHHHHHHHH
Confidence 9999999888889988888865 48999999999999999888777766654
No 16
>PRK15099 O-antigen translocase; Provisional
Probab=99.90 E-value=7.5e-21 Score=178.66 Aligned_cols=276 Identities=12% Similarity=0.001 Sum_probs=222.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhHHHHH
Q 018774 54 LWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYM 132 (350)
Q Consensus 54 ~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~~~~~ 132 (350)
+.|-+.....+.+...+.+++-..++.+ +|++++|.++...++...+......|++++....++|+ ++|+++.++.+
T Consensus 3 ~~k~~~~~~~~~~~~~~~~~l~~~i~ar~Lg~~~~G~~~~~~~~i~~~~~~~~~G~~~a~~~~ia~~--~~~~~~~~~~~ 80 (416)
T PRK15099 3 LAKASLWTAASTLVKIGAGLLVVKLLAVSFGPAGVGQAGNFRQLITVLGVLAGAGIFNGVTKYVAQY--HDQPQQLRAVV 80 (416)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCcHHHHHHHHHHHHHHHHHHHHcCCccceeeeeHHhc--CCCHHHHHHHH
Confidence 4566777788888888888888889999 79999999999998888655555788888888889887 67889999999
Q ss_pred HHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHHHHHH
Q 018774 133 QRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASL 211 (350)
Q Consensus 133 ~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~ 211 (350)
..++.+.++.++++++. +.+.+++...+..+++. ..++.+..+..++..+.....+.+|+.||++.++...+++.
T Consensus 81 ~~~~~l~~~~~~i~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lr~~~~~~~~~~~~~~~~ 156 (416)
T PRK15099 81 GTSSAMVLGFSTLLALVFLLAAAPISQGLFGHTDY----QGVVRAVALIQMGIAWANLLLAILKGFRDAAGNALSLIVGS 156 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChhH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999998886655 66788888877766643 23566666666677888899999999999999999999999
Q ss_pred HHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc-CCCcccCCCChHhHHhHHHHHHHHHHHHHHHHHHHH
Q 018774 212 LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG-GCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENW 290 (350)
Q Consensus 212 ~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~~~~~~~ 290 (350)
++|+.+ +++.+. ..|+.|+++|+.+++.+..+...++++|+ +.+.+..++ +.+++.+|+++++|.|..+++....+
T Consensus 157 ~~~i~l-~i~~~~-~~Gv~Ga~iat~i~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~k~ll~~g~p~~~~~~~~~i 233 (416)
T PRK15099 157 LIGVAA-YYLCYR-LGGYEGALLGLALVPALVVLPAGIMLIRRGTIPLSYLKP-SWDNGLAGQLGKFTLMALITSVTLPV 233 (416)
T ss_pred HHHHHH-HHHHHH-HhcchHHHHHHHHHHHHHHHHHHHHHHHccceehHhhhc-cCCHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999887 444442 24999999999999998887776666654 211111111 23567789999999999999999999
Q ss_pred HHHHHHHHHh-cCCChhhHHHHHHHHHHHHH-HHHHHhhHhhhhHhhhhhhh
Q 018774 291 YYRVLILMTG-NLQNAKIAVDALSICMSING-WESQICYYSISGDLDCNWCL 340 (350)
Q Consensus 291 ~~~~~~~~~~-~~g~~~~~vaa~~i~~~~~~-~~~~~~~~~~~a~~~~~~~~ 340 (350)
.....+.+++ .+|+. ++++|+.+.++.+ +...++.+++++..+.+++.
T Consensus 234 ~~~~~~~~l~~~~g~~--~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~ 283 (416)
T PRK15099 234 AYVMMRNLLAAHYSWD--EVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL 283 (416)
T ss_pred HHHHHHHHHHhcCCHH--HhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 9999999996 77864 5779999999977 45789999999999999985
No 17
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=99.89 E-value=2.1e-20 Score=179.90 Aligned_cols=232 Identities=16% Similarity=0.113 Sum_probs=196.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchh
Q 018774 47 FWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (350)
Q Consensus 47 ~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~ 126 (350)
+++..|++++.+.|..++++...+...+|+.+.+.+|++++++|+.+.++.++....+..+++++..|.+++++|++|++
T Consensus 218 ~~~~~k~~l~~~~p~~~~~~~~~~~~~id~~~~~~~~~~~v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~ 297 (502)
T TIGR01695 218 RDPGLKRFLKLFLPTTLGSSASQITLLINTALASFLEIGSVSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWN 297 (502)
T ss_pred CChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHH
Confidence 45678999999999999999999999999998666899999999999999886434467899999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCC----CHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchh
Q 018774 127 MLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQ----PDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTM 201 (350)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~ 201 (350)
+.++.++++......++++.+++ +.++++++.++.. ++|..+.+..++++++++.++..+..++.+.+++.||++
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~a~g~~~ 377 (502)
T TIGR01695 298 ELRDLLNQGIRLSLLLTIPSSFGLLILSIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLLRAFYARKDTR 377 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhccCCc
Confidence 99999999999999999988766 6688999988765 456777889999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHH
Q 018774 202 VIAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVAS 281 (350)
Q Consensus 202 ~~~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 281 (350)
.+++.++...++|++++++++. .+|+.|+++|+.+++.+..++..++.+|+.... ...+..+++.+..++.
T Consensus 378 ~~~~~~~~~~~i~i~l~~~l~~--~~G~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~as 448 (502)
T TIGR01695 378 TPFINSVISVVLNALLSLLLIF--PLGLVGIALATSAASMVSSVLLYLMLNRRLKGI-------LPFGVLKVLAKLVIAS 448 (502)
T ss_pred cCHHHHHHHHHHHHHHHHHHHH--HHhhhHHHHHHHHHHHHHHHHHHHHHHHhcCcC-------CchHHHHHHHHHHHHH
Confidence 9999999999999999999987 589999999999999999888877776551110 1123444556655555
Q ss_pred HHHHHH
Q 018774 282 GVMLCL 287 (350)
Q Consensus 282 ~l~~~~ 287 (350)
.++...
T Consensus 449 ~~m~~~ 454 (502)
T TIGR01695 449 AIIGGV 454 (502)
T ss_pred HHHHHH
Confidence 555443
No 18
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.85 E-value=4e-18 Score=161.02 Aligned_cols=205 Identities=14% Similarity=0.131 Sum_probs=190.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhh
Q 018774 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYM 127 (350)
Q Consensus 48 ~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~ 127 (350)
.+..|++++...|.+++.....+...+|+.+.+.+++.++++++.+.++.++....+..++++...|..|+...+||.++
T Consensus 194 ~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G~vs~l~YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~~~ 273 (451)
T PF03023_consen 194 DPNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEGSVSALNYAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDWEE 273 (451)
T ss_pred ChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHH
Confidence 45799999999999999999999999999999999999999999999999976567888999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcC----CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhH
Q 018774 128 LGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLG----QPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMV 202 (350)
Q Consensus 128 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~ 202 (350)
.++..++++...+.+.+|.++. +.+++++++++. .+.|..+....+++++++++|+.++...+...+.+.||+|.
T Consensus 274 ~~~~~~~~l~~~~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~~~~~ta~~l~~y~~~l~~~~l~~ll~r~fya~~~~~~ 353 (451)
T PF03023_consen 274 FRKTLRKALRLILLILIPASIGLIVLAEPIVRLLFERGAFTAEDTQLTASALRIYALGLPFYALNDLLSRVFYALGDTKT 353 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHccCCCCHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHccCcHh
Confidence 9999999999999999998766 669999998764 36666778899999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 203 IAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 203 ~~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
+++.++++.++|++++.++.. .+|..|.++|+.++.++..+..++.++|+
T Consensus 354 ~~~~~~~~~~lni~l~~~l~~--~~g~~Glala~sl~~~i~~~~l~~~l~r~ 403 (451)
T PF03023_consen 354 PVRISVISVVLNIILSILLVP--FFGVAGLALATSLSAIISALLLYILLRRR 403 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999988 79999999999999999999888888776
No 19
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=99.84 E-value=2.5e-18 Score=162.19 Aligned_cols=200 Identities=16% Similarity=0.111 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhh
Q 018774 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYM 127 (350)
Q Consensus 48 ~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~ 127 (350)
++..|++++.+.|..++++.......+-+.+++++|++++|+++++.++.++. +.+..|++++.+++++|++|+||+|+
T Consensus 228 ~~~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~G~~alAa~~I~~~i~~~~-~~~~~gl~~a~~~lvg~~~Ga~~~~~ 306 (441)
T PRK10367 228 RGNFRRLLALNRDIMLRSLLLQLCFGAITVLGARLGSDIIAVNAVLMTLLTFT-AYALDGFAYAVEAHSGQAYGARDGSQ 306 (441)
T ss_pred HHHHHHHHHhCchHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHHHHHHHHcCCCHHH
Confidence 35789999999999999999999999999999999999999999999999885 78999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcc---chhHH
Q 018774 128 LGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQL---KTMVI 203 (350)
Q Consensus 128 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g---~~~~~ 203 (350)
+|+..+.+..++++.+++++++ +.+.+++..+|..|+|+.+.+..++++.++..+.........+.+++.+ |++.+
T Consensus 307 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lFt~d~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~g~lrg~dt~~~ 386 (441)
T PRK10367 307 LLDVWRAACRQSGIVALLFSLVYALAGEHIIALLTSLPQIQQLADRYLIWQVILPLVGVWCYLLDGMFIGATRAAEMRNS 386 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCccchHHHHHH
Confidence 9999999999999999887765 5588899999999999999999999998876443324444444455555 59999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 204 AWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 204 ~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
++.++++..+ .++... .+|+.|+|++..+++.+..+...+.++++
T Consensus 387 ~~~~~~~~~~----~~~~~~--~~g~~Gvw~a~~~~~~~~~i~~~~~~~~~ 431 (441)
T PRK10367 387 MAVAAAGFAL----TLLTLP--WLGNHGLWLALTVFLALRGLSLAAIWRRH 431 (441)
T ss_pred HHHHHHHHHH----HHHHHH--HcCchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999887543 112223 57999999999999999988887766655
No 20
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.82 E-value=1.9e-16 Score=148.18 Aligned_cols=233 Identities=15% Similarity=0.128 Sum_probs=200.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhH
Q 018774 49 IESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYML 128 (350)
Q Consensus 49 ~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~ 128 (350)
+..|++.+.-.|..++..+.++..++|+.+.+.+.+.+++.+.++..+.++..-++..++++...|..|++..++|.++.
T Consensus 229 ~~lk~~~~~~~p~~l~~sisQi~lli~~~iAS~l~~Gsis~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~~~~ 308 (518)
T COG0728 229 PGLKRFLKLMLPALLGVSISQINLLIDTAIASFLAEGSVSWLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDWPEF 308 (518)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCChHHH
Confidence 68999999999999999999999999999999999999999999999999665689999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcC----CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHH
Q 018774 129 GVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLG----QPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVI 203 (350)
Q Consensus 129 ~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~ 203 (350)
++..++++.+++++++|.++. +.+++++++.+. .+++......+.+..+.++.+++.+..++...+++++|+|.|
T Consensus 309 ~~~l~~~i~l~lll~lP~~~~l~~la~piv~~Lf~rG~F~~~d~~~ta~~L~~y~~gL~~~~L~~ll~~~FYAr~d~ktP 388 (518)
T COG0728 309 LKLLDWGLRLTLLLTLPASAGLLVLAEPIVSLLFERGAFTAEDVLMTAEALAAYSLGLIPFALVKLLSRVFYAREDTKTP 388 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCChHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHccCCCcC
Confidence 999999999999999998776 669999998764 245556678889999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHH
Q 018774 204 AWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGV 283 (350)
Q Consensus 204 ~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l 283 (350)
+++++++.++|+++++++.. .+|..|.++++.++.+++....++..+|+...... ..|.... ..|..+-.++
T Consensus 389 ~~i~ii~~~~n~~l~~~l~~--~~~~~giala~s~a~~~~~~ll~~~l~k~~~~~~~-----~~~~~~~-~~k~~l~~~i 460 (518)
T COG0728 389 MKIAIISLVVNILLNLLLIP--PLGHVGLALATSLAAWVNALLLYYLLRKRLVYLPG-----RGWGLFL-ILKLLLASAI 460 (518)
T ss_pred hHHHHHHHHHHHHHHHHHHh--hccchHHHHHHHHHHHHHHHHHHHHHHHhcCCCcc-----chhhHHH-HHHHHHHHHH
Confidence 99999999999999988777 68999999999999999888888877776322112 2233333 4555555555
Q ss_pred HHHHHH
Q 018774 284 MLCLEN 289 (350)
Q Consensus 284 ~~~~~~ 289 (350)
+....+
T Consensus 461 ~~~~~~ 466 (518)
T COG0728 461 MAAALL 466 (518)
T ss_pred HHHHHH
Confidence 544333
No 21
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=99.82 E-value=5.2e-18 Score=162.72 Aligned_cols=205 Identities=15% Similarity=0.122 Sum_probs=173.6
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cCh------hHHHHH----HHHHHHHHHHHHHHHHHHHHhHH
Q 018774 45 RRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGD------LELAAI----SIANTVVVAFNFGLLLGMASALE 113 (350)
Q Consensus 45 ~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~------~~~a~~----~~a~~l~~~~~~~~~~g~~~a~~ 113 (350)
+.+++.+|++++.+.|..++++...+.+.+|+.++++ +++ ++.+.+ +.+.++..+. ..+..+++++..
T Consensus 218 ~~~~~~~k~l~~~~~p~~l~~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~~~-~~~~~~l~~~~~ 296 (488)
T TIGR02900 218 SEGKALLFDLFSVSLPLTLSRFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLTFP-AVITSSLSTALV 296 (488)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHHhH-HHHHHHHHHHHH
Confidence 3456789999999999999999999999999999987 322 222232 3445566654 567889999999
Q ss_pred HHHHhHhcccchhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH
Q 018774 114 TLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQR 192 (350)
Q Consensus 114 ~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 192 (350)
|.+++++|+||+++.++..++...++..++++.+++ ..++++++.++..++ .+..++++++++.++..+.....+
T Consensus 297 p~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~----~~~~~l~i~~~~~~~~~~~~~~~~ 372 (488)
T TIGR02900 297 PDISEAMAKKNYSSIEKRINQAIKISLLLGLITTVILLVIPDELGALFYGRP----DAGNFIRVLAPSFPFLYFSAPLQS 372 (488)
T ss_pred HHHHHHHHcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC----chHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999987665 568888888876543 356789999999999999999999
Q ss_pred HHHHccchhHHHHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 193 FLQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 193 ~l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
.+++.||+|..++.++++.++|++++++++....+|+.|+++++.+++.+..++..+..+|.
T Consensus 373 ~l~~~g~~~~~~~~~~~~~i~~i~l~~~l~~~~~~G~~Gaaia~~i~~~~~~~~~~~~~~~~ 434 (488)
T TIGR02900 373 ILQGLGKQKVALRNSLIGAIVKIILLFVLTSIPSINIYGYAITFIITSVLVTILNLAEIKKN 434 (488)
T ss_pred HHHhcCcchHHHHHHHHHHHHHHHHHHHHHhccccccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999998732278999999999999999988887777654
No 22
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=99.80 E-value=6.3e-20 Score=149.56 Aligned_cols=160 Identities=25% Similarity=0.404 Sum_probs=153.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhHHHHHHHHHHHH
Q 018774 60 PTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVL 139 (350)
Q Consensus 60 p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 139 (350)
|..+++++..+.+.+|+.+++++|++++++++++.++.+.. ..+..|+++|..+.+||++|++|++++++.+++++.++
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g~~~~a~~~i~~~~~~~~-~~~~~g~~~a~~~~~s~~~G~~~~~~~~~~~~~~~~~~ 79 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLGPEALAAYGIASSIFSIL-FMLIFGLATALQILISQNIGAGDYKRAKKVVRQGLLLS 79 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCTTCCCCHCCHHHHHHHHH-HHHHHHHHHHHHHHHCCCCCSSSTTTCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHHHH-hhhcccccccccceeecccccccccccccccccccccc
Confidence 89999999999999999999999999999999999999985 67999999999999999999999999999999999999
Q ss_pred HHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHHHHHH-HHHHHH
Q 018774 140 FICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASL-LVHLLV 217 (350)
Q Consensus 140 ~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~-~~~i~l 217 (350)
.+++++..++ +.+.+++..+++.|+|+.+.+..|+++..++.++..+.....+++++.||++.+++.++++. ++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l 159 (162)
T PF01554_consen 80 LIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSGILQGIGRTKIAMYISIISFWIINIPL 159 (162)
T ss_dssp HHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCCCCGCCSTHCCCHHHHHHHHHHHHHHH
T ss_pred hhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHHHHHHCCcHHHHHHHHHHHHHHHHHhH
Confidence 9999988776 66899999999999999999999999999999999999999999999999999999999999 999999
Q ss_pred HHH
Q 018774 218 TWL 220 (350)
Q Consensus 218 ~~~ 220 (350)
+|+
T Consensus 160 ~yl 162 (162)
T PF01554_consen 160 AYL 162 (162)
T ss_dssp HHH
T ss_pred HhC
Confidence 875
No 23
>PRK15099 O-antigen translocase; Provisional
Probab=99.78 E-value=1.6e-16 Score=149.27 Aligned_cols=202 Identities=7% Similarity=-0.029 Sum_probs=174.6
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-ccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhccc
Q 018774 45 RRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAG-HLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGK 123 (350)
Q Consensus 45 ~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~-~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~ 123 (350)
+.+++..|++++++.|..++++...+...+|+.+++ ++|++++|.|+.+.++.+.+...+..+++++.+|.++++ +
T Consensus 208 ~~~~~~~k~ll~~g~p~~~~~~~~~i~~~~~~~~l~~~~g~~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~---~ 284 (416)
T PRK15099 208 SWDNGLAGQLGKFTLMALITSVTLPVAYVMMRNLLAAHYSWDEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL---T 284 (416)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---C
Confidence 345778999999999999999999999999999998 589999999999999988544678899999999999995 6
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhH
Q 018774 124 KYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMV 202 (350)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~ 202 (350)
|+++.++.+++.......++++.++. ++++++++.++.+++ .+.+.+++++++++.++......+...+.+.++++.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~a~~ii~l~~g~~--~~~~~~~~~~l~~~~~l~~~~~~~g~~~~~~~~~~~ 362 (416)
T PRK15099 285 EKRDITREIVKALKFVLPAVAAASFTVWLLRDFAIWLLFSNK--FTAMRDLFAWQLVGDVLKVGAYVFGYLVIAKASLRF 362 (416)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 78889999999999998888877665 568999999887765 334677899999999888887777777778889999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHh
Q 018774 203 IAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVAC 253 (350)
Q Consensus 203 ~~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~ 253 (350)
.....+...++++++++++++ .+|..|+++++.+++.+..++..+...+
T Consensus 363 ~~~~~~~~~~l~i~l~~~li~--~~G~~G~a~a~~is~~~~~~~~~~~~~~ 411 (416)
T PRK15099 363 YILAEVSQFTLLTGFAHWLIP--LHGALGAAQAYMATYIVYFSLCCGVFLL 411 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHH--HhhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999998888999999999998 6899999999999999988877665543
No 24
>PRK10459 colanic acid exporter; Provisional
Probab=99.75 E-value=1.9e-15 Score=145.11 Aligned_cols=202 Identities=14% Similarity=0.007 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccch
Q 018774 47 FWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (350)
Q Consensus 47 ~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~ 125 (350)
+++..|++++++.|...+++...+...+|+.++++ +|++++|.|+.+.++.+.....+...++....|..++. ++|.
T Consensus 202 ~~~~~k~ll~~~~~~~~~~~~~~~~~~~d~~~lg~~lg~~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~--~~~~ 279 (492)
T PRK10459 202 SLASVKPNLSFGAWQTAERIINYLNTNIDTILIGRILGAEVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKI--QDDT 279 (492)
T ss_pred cHHHHHHHHhhhHHHHHHHHHHHHHhcCchhhhhHhhchHhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHh--cCCH
Confidence 35678999999999999999999999999999999 79999999999999988644455666778888999886 5688
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHH
Q 018774 126 YMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA 204 (350)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 204 (350)
++.++.+++.......+++|++++ ...+++++.++.+++ ...+...+++++++..+..+.......+++.||+|..+
T Consensus 280 ~~~~~~~~~~~~~~~~~~~p~~~~l~~~a~~ii~ll~g~~--~~~a~~~l~il~~~~~~~~~~~~~~~~l~a~g~~~~~~ 357 (492)
T PRK10459 280 EKLRVGFLKLLSVLGIINFPLLLGLMVVSNNFVPLVFGEK--WNSAIPILQLLCIVGLLRSVGNPIGSLLLAKGRADLSF 357 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhcChh--HHhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCccchhH
Confidence 899999999999999999997766 558888888776654 34577899999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 205 WVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 205 ~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
+.+++..+++++..+.+.. .+|+.|+++++.+++.+......++..|+
T Consensus 358 ~~~~~~~~~~i~~~~~~~~--~~G~~g~a~a~~i~~~~~~~~~~~~~~~~ 405 (492)
T PRK10459 358 KWNVFKTFLFIPAIVIGGQ--LAGLIGVALGFLLVQIINTILSYFLMIKP 405 (492)
T ss_pred HHHHHHHHHHHHHHHHHHh--hccHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999988888887777766 68999999999999998888777766544
No 25
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.74 E-value=1.3e-14 Score=137.30 Aligned_cols=259 Identities=17% Similarity=0.101 Sum_probs=210.4
Q ss_pred cChh-HHHHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhHhcccchhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHH
Q 018774 82 LGDL-ELAAISIANTVVVAFNFGLL-LGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLK 158 (350)
Q Consensus 82 lg~~-~~a~~~~a~~l~~~~~~~~~-~g~~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~ 158 (350)
+|.. +..+|..+.++.+.+...+. .+++++..|..++.. ++++++.++..+....+..+.++.++++ +.++++++.
T Consensus 5 fG~s~~~Daf~~A~~ip~~l~~l~~~gal~~~~IP~~~~~~-~~~~~~~~~f~~~~~~~~~~~~~~l~~l~~lfa~~iv~ 83 (451)
T PF03023_consen 5 FGASAEADAFFVAFTIPNFLRSLLAGGALSAAFIPVFSKAR-EKGEEEARRFISTLLTILLIISLLLTLLGILFAPPIVR 83 (451)
T ss_pred hcCCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5654 56689999999997643443 568999999999998 8889999999998888887777766555 668889888
Q ss_pred hc--CCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHHHHHHHHHHHHHHHHHhhcCCc---cchHH
Q 018774 159 LL--GQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLG---LIGTA 233 (350)
Q Consensus 159 ~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~G---~~G~a 233 (350)
.+ +.+++..+.+.+++++..+..++..+..++.+++|+++|...+....++.++..++..+++.. ..| +.+.+
T Consensus 84 ~la~g~~~~~~~la~~l~~i~~~~~~~~~l~~i~~a~L~~~~~F~~~~~~~l~~N~~~I~~~~~~~~--~~~~~~i~~la 161 (451)
T PF03023_consen 84 LLAPGFSPETIELAVQLLRILAPSILFIGLSSIFSAILNAHRRFLIPALSPLLFNLSIILSLLLLSN--SWGQENIYALA 161 (451)
T ss_pred HHCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcchHHHHHHHHHHHHHHHHHHHHHH--hcCchHHHHHH
Confidence 87 457788899999999999999999999999999999999999999988888775554443333 567 88999
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChhhHHHHHH
Q 018774 234 ITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENWYYRVLILMTGNLQNAKIAVDALS 313 (350)
Q Consensus 234 ~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~~~~~~~~~~~~~~~~~~~g~~~~~vaa~~ 313 (350)
+|..++..+..++.....+|...+.+.+. ....+.+|++++...|..+..........+.+.+++.++++. +++.+
T Consensus 162 ~g~~~g~~~~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G~--vs~l~ 237 (451)
T PF03023_consen 162 WGVLIGAIIQFLIQLPYLRRFGFRFRPKF--DWRDPNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEGS--VSALN 237 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCcccccC--CCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccH--HHHHH
Confidence 99999999999888888776643322211 112346889999999999999999999999999999999775 55999
Q ss_pred HHHHHHHHHH-HHhhHhhhhHhhhhhhhhhcccCC
Q 018774 314 ICMSINGWES-QICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 314 i~~~~~~~~~-~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
.+.++.++.. .+..++++..-+-.++...++|.+
T Consensus 238 YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~~ 272 (451)
T PF03023_consen 238 YAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDWE 272 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHH
Confidence 9999999876 557789988888888888877764
No 26
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.70 E-value=1.3e-14 Score=138.96 Aligned_cols=187 Identities=20% Similarity=0.233 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccch
Q 018774 47 FWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (350)
Q Consensus 47 ~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~ 125 (350)
.++..|+.++.+.|...+.+...+.+.+|+.++++ +|++++|.|+.+.++.... ..+..+++....|.+++.+.++|.
T Consensus 208 ~~~~~~~~l~~~~p~~~~~~~~~l~~~~D~~~i~~~l~~~~vG~Y~~a~~i~~~~-~~~~~~l~~~l~P~~s~~~~~~~~ 286 (480)
T COG2244 208 SLALLKELLRFGLPLLLSSLLNFLFTNIDTLLLGLFLGPAQVGIYSAAQRLVSLL-LIVASALNRVLFPALSRAYAEGDR 286 (480)
T ss_pred hhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHhhhhHheecccccHHHHHH-HHHHHHHHHHHHHHHHHHHHcCcH
Confidence 47899999999999999999999999999999999 7999999999888887774 788899999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHH
Q 018774 126 YMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA 204 (350)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 204 (350)
++.++..++.......+++|..++ ..++++++..+.+++.. .+...+++++++.++..+.......+++.|+++..+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~i~~~fg~~~~--~~~~~l~il~~~~~~~~~~~~~~~~l~~~g~~~~~~ 364 (480)
T COG2244 287 KALKKLLRQSLKLLLLISIPALLGLLLLAPPIITLLFGEKYA--SAAPILQLLALAGLFLSLVSLTSSLLQALGKQRLLL 364 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhheeecCCccc--chhHHHHHHHHHHHHHHHHHHHHHHHHHcCcchhhH
Confidence 999999999999999999998776 55888898887666532 277789999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHH
Q 018774 205 WVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSF 238 (350)
Q Consensus 205 ~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i 238 (350)
+.+.++.++|++++++++. .+|+.|++++++.
T Consensus 365 ~~~~~~~i~~~~l~~~li~--~~g~~g~~~a~~~ 396 (480)
T COG2244 365 LISLISALLNLILNLLLIP--RFGLIGAAIATAS 396 (480)
T ss_pred HHHHHHHHHHHHHHhHHHH--hhhhhhHHHHHHH
Confidence 9999999999999999998 7899999999933
No 27
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=99.67 E-value=1.4e-12 Score=115.02 Aligned_cols=271 Identities=18% Similarity=0.150 Sum_probs=198.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhHHHHHH
Q 018774 55 WHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQ 133 (350)
Q Consensus 55 ~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~~~~~~ 133 (350)
+|-+.-....++...+.+++-..++.| +|+++.|.++....+.+++......|++++....+++...+ +++.+....
T Consensus 2 ~k~~~~~~~~~~~~~~~~~~~~~il~r~l~~~~~G~~~~~~~~~~~~~~~~~~G~~~~~~r~~~~~~~~--~~~~~~~~~ 79 (273)
T PF01943_consen 2 LKNSLWLFLSNILSALIGFITIPILARYLGPEEYGIYSLALSIVSLLSILADLGLSQAIVRFIAEYKDK--KELRSAYFS 79 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHhhhh--HHHHHHHHH
Confidence 466677788888888999999999999 79999999999999988765556888999988888876432 344444444
Q ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHHHHHHHH
Q 018774 134 RSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLV 213 (350)
Q Consensus 134 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~ 213 (350)
.......+.++.......... .+..++ ... .+........++.........++++.++.+.....++...+.
T Consensus 80 ~~~~~~~~~~~i~~~~~~~~~----~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (273)
T PF01943_consen 80 SVLFLLLIFSLIFLLILLIAS----FFGNPS-LSL---ILIILALLILILSSLSSVFSGLLQGLQRFKYIAISNIISSLL 151 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHH----HcCCch-HHH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 444444444333333322222 333332 221 122222222256778888999999999999999999999888
Q ss_pred HHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHHHHHHHHHHHH
Q 018774 214 HLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENWYYR 293 (350)
Q Consensus 214 ~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~~~~~~~~~~ 293 (350)
..+...+++.. ..++.+..++..++..+..++..++.+|+. +.+ ....+++..|++++.+.|..+..........
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (273)
T PF01943_consen 152 SLLLILLLLFL-GSSLWGFLLGLVISSLVSLIISLFYLRRKL-RPR---FSFFSKKFFKEILRFGLPLFLSSLLSWLYSQ 226 (273)
T ss_pred HHHHHHHHHHH-hhhHHHHHHHHHHHHHHHHHHHHHHHHHHH-ccc---ccccchHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 77766666653 445889999999999888888877777652 111 2223367889999999999999999999999
Q ss_pred HHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhh
Q 018774 294 VLILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLL 341 (350)
Q Consensus 294 ~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~ 341 (350)
.+..+++.+... .+++.|+++.++......++.++.+...+..++++
T Consensus 227 ~d~~ii~~~~g~-~~vg~Y~~a~~l~~~~~~~~~~~~~~~~P~~s~l~ 273 (273)
T PF01943_consen 227 IDRLIIGYFLGP-EAVGIYSVAYRLASAISFLLSSISTVLFPRLSRLW 273 (273)
T ss_pred hHHHHHHHhCCH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhC
Confidence 999999998543 34779999999999999999999998888877653
No 28
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.66 E-value=1.5e-12 Score=122.28 Aligned_cols=293 Identities=11% Similarity=-0.012 Sum_probs=225.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cChh-HHHHHHHHHHHHHHHHHHH-HHHHHHhHHHHHHhHhcccchhh
Q 018774 51 SKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDL-ELAAISIANTVVVAFNFGL-LLGMASALETLCGQAFGGKKYYM 127 (350)
Q Consensus 51 ~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~-~~a~~~~a~~l~~~~~~~~-~~g~~~a~~~~~s~~~g~~~~~~ 127 (350)
-++++|.+.-.....++..+.+++-..+++. +|+. ...++.++.++.+.+--.+ -.+++++..|...++..+++.++
T Consensus 6 ~~sllks~~~vs~~Tl~SRi~G~vRd~~iA~~fGa~~~aDAF~vAf~iPN~lRrlfaegafs~aFVPv~~~~~~~~~~~~ 85 (518)
T COG0728 6 KMSLLKSLIIVSSATLLSRILGFVRDVLIAAAFGAGAAADAFFVAFKLPNLLRRLFAEGAFSSAFVPVLAEAKKKEGEEA 85 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCchHHHHHHHHHHhHHHHHHHHhchhHhhhhhHHHHHHHHcchhhH
Confidence 3455666666777777777788887777888 7885 5679999999999653332 34468999999999988887888
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhc-CC--CHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHH
Q 018774 128 LGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLL-GQ--PDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVI 203 (350)
Q Consensus 128 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~-~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~ 203 (350)
.++...........+.+..+++ .++.++++... .. |++....+....+++.+..++..+.....+.+|+.+|...+
T Consensus 86 ~~~f~~~v~~~l~~~ll~vt~L~~l~~p~iv~~~~~~g~~~~~~~~a~~l~~i~~Pyl~~isL~al~~aiLNs~~~F~~~ 165 (518)
T COG0728 86 ARFFSRLVTGLLTLVLLLVTLLGILFAPWLVRLLLAPGFDETDKFLAVLLTRILFPYLLFISLSALFGAILNSRNRFFIP 165 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeechh
Confidence 8877777775555555555444 66777777444 33 23333358888899999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHH
Q 018774 204 AWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGV 283 (350)
Q Consensus 204 ~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l 283 (350)
...-+.-++.-+.....+.+..+.-..+.++++.++-+++.++.+..++|.....+++.. .+-+.+|++.+...|..+
T Consensus 166 a~aPvl~Nv~~I~~~l~~~~~~~~~~~~La~gvl~Gg~~Q~l~~lp~l~~~g~~~~p~~~--~~~~~lk~~~~~~~p~~l 243 (518)
T COG0728 166 AFAPVLLNVSVIGLALFLGPYFDPPLLALAWGVLIGGLLQLLVQLPALRKAGLLIKPRFG--FKDPGLKRFLKLMLPALL 243 (518)
T ss_pred hhhHHHHHHHHHHHHHHhccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHcccccCCCCC--CCchhHHHHHHHHHHHHH
Confidence 999888887766555555554222367888899999999999999999888433222211 111578899999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHH-HHhhHhhhhHhhhhhhhhhcccCC
Q 018774 284 MLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWES-QICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~-~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
.....++...+++.+++.+.++. ++.++.+.+++++.. .+..++++..-+-.+++...+|.|
T Consensus 244 ~~sisQi~lli~~~iAS~l~~Gs--is~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~~ 306 (518)
T COG0728 244 GVSISQINLLIDTAIASFLAEGS--VSWLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDWP 306 (518)
T ss_pred HHHHHHHHHHHHHHHHHhhcccc--HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCChH
Confidence 99999999999999999997765 459999999999877 778899998889999988888765
No 29
>PRK10459 colanic acid exporter; Provisional
Probab=99.56 E-value=9.4e-12 Score=119.64 Aligned_cols=266 Identities=6% Similarity=0.006 Sum_probs=187.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhHHH
Q 018774 52 KKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGV 130 (350)
Q Consensus 52 k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~~~ 130 (350)
++..+-+....++++...+.+++...+++| +|+++.|.++.+..+...+......|++++.. |. +|. .++
T Consensus 5 ~~~~~g~~w~~~~~~~~~~~~~i~~~ilaR~L~p~~~G~~~~~~~~~~~~~~~~~~Gl~~aii----~~---~~~--~~~ 75 (492)
T PRK10459 5 EKTISGAKWTAISTVIIIGLQLVQLTVLARILDNHQFGLLTMSLVIIGFADTLSDMGIGASII----QR---QDI--SHL 75 (492)
T ss_pred HHHHccccHHHHHHHHHHHHHHHHHHHHHHhCCHHHccHHHHHHHHHHHHHHHHHcCHHHHHH----hc---ccC--CHH
Confidence 556777778888999999999999999999 79999999999999988755555566666542 22 111 123
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-hhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHHHH
Q 018774 131 YMQRSWIVLFICCVLLLPLYV-FASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLA 209 (350)
Q Consensus 131 ~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~ 209 (350)
.......+....++.+.++.+ +.+++...+ .+++. ...+++..+..++..+.......++..++.+........
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~r~~~f~~~a~~~~~ 150 (492)
T PRK10459 76 QLSTLYWLNVGLGIVVFVLVFLLSPLIADFY-HNPEL----APLIKTLSLAFVIIPIGQQFRALLQKELEFNKLAKIEIS 150 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHc-CChhh----HHHHHHHHHHHHHHHHhhHHHHHHHHHhhhHHHHHHHHH
Confidence 344555666666665554433 445544444 44443 345777778888888888899999999999999888888
Q ss_pred HHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHHHHHHHH
Q 018774 210 SLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLEN 289 (350)
Q Consensus 210 ~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~~~~~~ 289 (350)
..+...++...+... ++|+.+.+++..++..+..+...+.. +++++.++ +.+++.+|++++.+.|.........
T Consensus 151 ~~i~~~~~~i~~~~~-~~g~~~l~~~~~~~~~~~~l~~~~~~-~~~~~~~~----~~~~~~~k~ll~~~~~~~~~~~~~~ 224 (492)
T PRK10459 151 AVVAGFTFAVVSAFF-WPGALAAILGYLVNSSVRTLLFGYFG-RKIYRPAL----HFSLASVKPNLSFGAWQTAERIINY 224 (492)
T ss_pred HHHHHHHHHHHHHHH-CCcHHHHHHHHHHHHHHHHHHHHHHh-cccCCccc----eecHHHHHHHHhhhHHHHHHHHHHH
Confidence 887777666665543 78999999999999877765543332 22222211 1234578899999999999999999
Q ss_pred HHHHHHHHHHhcC-CChhhHHHHHHHHHHHHHHHHHH-hhHhhhhHhhhhhh
Q 018774 290 WYYRVLILMTGNL-QNAKIAVDALSICMSINGWESQI-CYYSISGDLDCNWC 339 (350)
Q Consensus 290 ~~~~~~~~~~~~~-g~~~~~vaa~~i~~~~~~~~~~~-~~~~~~a~~~~~~~ 339 (350)
....++..+++++ |.+ +++.|+.+.++.+..... ...++...-+..++
T Consensus 225 ~~~~~d~~~lg~~lg~~--~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~ 274 (492)
T PRK10459 225 LNTNIDTILIGRILGAE--VLGGYNLAYNVATVPPMKINPIITRVAFPVFAK 274 (492)
T ss_pred HHhcCchhhhhHhhchH--hhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHH
Confidence 9999999998887 543 467999999988764433 33344444444454
No 30
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=99.49 E-value=1.5e-12 Score=119.03 Aligned_cols=133 Identities=21% Similarity=0.292 Sum_probs=121.4
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhccc
Q 018774 44 TRRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGK 123 (350)
Q Consensus 44 ~~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~ 123 (350)
++.+++..|++++++.|.+++++...+...+|+.+++++|++++++|+++.++.+.. ..+..+++++..|.+++++|++
T Consensus 208 ~~~~~~~~k~~~~~~~P~~~~~l~~~~~~~~~~~i~~~~g~~~v~~~~~a~~~~~~~-~~~~~~~~~a~~~~~~~~~~~~ 286 (342)
T TIGR00797 208 LKPDWEVLKRLLKLGLPIAFRVILESLSFALLALLVARLGSIALAAHQIALNVESLL-FMPAFGFGIAVSILVGQALGAG 286 (342)
T ss_pred cCCCHHHHHHHHHhCchHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCC
Confidence 445677899999999999999999999999999999999999999999999998874 6889999999999999999999
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHH
Q 018774 124 KYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWL 177 (350)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (350)
|+++.++..+++....+.++++..++ +.+.+++.+++..|+++.+.+..++++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T TIGR00797 287 DPKRAKEVARVALKLSLLLGLVLAIILILFREFIARLFTNDPEVLELAAIYLIFV 341 (342)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHh
Confidence 99999999999999999999987766 5588999999999999999988888764
No 31
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.47 E-value=3.9e-11 Score=114.99 Aligned_cols=281 Identities=13% Similarity=0.059 Sum_probs=202.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhH
Q 018774 50 ESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYML 128 (350)
Q Consensus 50 ~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~ 128 (350)
..+++.|-+.-...+++...+..++....++| +|+++.|.++.+..+...+......|+..+....+++..+++++...
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lar~lg~~~~G~~~~~~~~~~~~~~i~~~G~~~ai~r~ia~~~~~~~~~~~ 83 (480)
T COG2244 4 LKKKLIKGALWLLLGTLISALLGLITIPLLARLLGPEGFGLYALALAIIGLFSILADFGLPAAITREIAEYREKGEYLLL 83 (480)
T ss_pred HHHHHHhhchHHHHHHHHHHHHHHHHHHHHHHHhCcccceeeehHHHHHHHHHHHHHcCCcHHHHHHHHHhhcccHHHHH
Confidence 56778888888899999999999999999999 89999999999999999776666688999988888888766665555
Q ss_pred HHH-HHHHHHHHHHHHHHHHHHHHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHH
Q 018774 129 GVY-MQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVS 207 (350)
Q Consensus 129 ~~~-~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~ 207 (350)
+.. ...........+++......+..+. ++ .....+++..++.+.........+.+|+.++.+......
T Consensus 84 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (480)
T COG2244 84 ILLSVLLLLLLALILLLLLLLIAYLLAPI------DP----VLALLLRILSLALLLLPLSSVLRGLFQGFGRFGPLALSI 153 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhccc------Ch----hhHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccchhHH
Confidence 555 4444444444444433332222222 22 233456788899999999999999999999999999884
Q ss_pred HHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHHHHHH
Q 018774 208 LASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCL 287 (350)
Q Consensus 208 ~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~~~~ 287 (350)
+.. ..-+...+.+.. ....+..++...+......+...+..+++.+.....+ +..++.+++.++.++|..+....
T Consensus 154 ~~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~p~~~~~~~ 228 (480)
T COG2244 154 VSS-IFLLAAVFALLF---AALGLAVWALVLGAVVSLLVLLILLGKKKRGLKRPIL-RFSLALLKELLRFGLPLLLSSLL 228 (480)
T ss_pred HHH-HHHHHHHHHHHH---HhhhHHHHHHHHHHHHHHHHHHHHHHHhhhhcccccc-CchhHHHHHHHHHhhHHHHHHHH
Confidence 443 111222222221 3444556666666666555555544322111111111 12467899999999999999999
Q ss_pred HHHHHHHHHHHHhcC-CChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCC
Q 018774 288 ENWYYRVLILMTGNL-QNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDID 347 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~-g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~ 347 (350)
......++..+++.+ |.. .++.|+.+.++......+..+++.+.-+..++.+.++|.|
T Consensus 229 ~~l~~~~D~~~i~~~l~~~--~vG~Y~~a~~i~~~~~~~~~~l~~~l~P~~s~~~~~~~~~ 287 (480)
T COG2244 229 NFLFTNIDTLLLGLFLGPA--QVGIYSAAQRLVSLLLIVASALNRVLFPALSRAYAEGDRK 287 (480)
T ss_pred HHHHHHHHHHHHHHHhhhh--HheecccccHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHH
Confidence 999999999999988 533 4668998899999999999999999999999988887765
No 32
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=99.45 E-value=1.4e-09 Score=94.71 Aligned_cols=244 Identities=15% Similarity=0.127 Sum_probs=168.7
Q ss_pred HHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhHHHHHHHHHHHHHHHHHHHHHH
Q 018774 71 MFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPL 149 (350)
Q Consensus 71 ~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 149 (350)
.+++-..+++| +|+++.|.++....+..+.......|+.+.... ..++|+++.++..........+.++...++
T Consensus 3 ~~f~~~~~lar~l~~~~~G~~~~~~s~~~~~~~~~~~g~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (251)
T PF13440_consen 3 INFLFLILLARYLGPEDFGIYALIFSIVSILSIVASLGLRQSLVR-----SAARDKQDIRSLLRFSLLVSLLLAVILAIL 77 (251)
T ss_pred HHHHHHHHHHHHCCHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHH-----hhccCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 45667778888 899999999999999887544445566555433 233566667777776666555555443332
Q ss_pred HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHHHHHHHHHHHHHHHHHhhcCCcc
Q 018774 150 YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLGL 229 (350)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~G~ 229 (350)
.. .+...+ .+++. ..++....+..+.........+.+++.+|.+..........+...++..++... +.++
T Consensus 78 ~~---~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 148 (251)
T PF13440_consen 78 AI---LIAYFF-GDPEL----FWLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRSLLRLLLLVLLLYL-GLNL 148 (251)
T ss_pred HH---HHHHHh-CChhH----HHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHHHHHHH-HhhH
Confidence 11 111122 33322 234566777788889999999999999999999999999988775444444442 4488
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-CCChhhH
Q 018774 230 IGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENWYYRVLILMTGN-LQNAKIA 308 (350)
Q Consensus 230 ~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~~~~~~~~~~~~~~~~~~-~g~~~~~ 308 (350)
.+..++..++.++..++.+...+++ .+ ..+ ..+.. +..+.+.|..+..............+++. +|.+ +
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~--~ 218 (251)
T PF13440_consen 149 WSILLAFIISALLALLISFYLLRRK-LR--LSF----KFSWR-RLLKYGLPFSLSSLLSWLLSQIDRLLIGYFLGPE--A 218 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhccc-cC--CCc----hhhHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHH--H
Confidence 8888998888887776655533222 11 111 12222 47899999999999999999999999999 6644 4
Q ss_pred HHHHHHHHHHHHHHH-HHhhHhhhhHhhhhh
Q 018774 309 VDALSICMSINGWES-QICYYSISGDLDCNW 338 (350)
Q Consensus 309 vaa~~i~~~~~~~~~-~~~~~~~~a~~~~~~ 338 (350)
++.|+++.++..... .+..++++...+-.+
T Consensus 219 ~g~y~~a~~l~~~~~~~~~~~i~~~~~p~la 249 (251)
T PF13440_consen 219 VGIYSVAQRLASLPASLLSSAISSVFFPKLA 249 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 669999999999888 888888877665444
No 33
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=99.14 E-value=1.1e-10 Score=110.12 Aligned_cols=206 Identities=16% Similarity=0.086 Sum_probs=180.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCh--hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccch
Q 018774 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGD--LELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (350)
Q Consensus 48 ~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~--~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~ 125 (350)
.+.+++++++++|..+...++.-...+-....|.++. .++++.++........ ..+..+++.+..+.+++..|++|.
T Consensus 243 ~~~~~~~~~lai~s~~miclE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~~~-~~~~~~~~~a~strv~neLGag~p 321 (473)
T KOG1347|consen 243 FDSWGPFFALAIPSAVMICLEWWAYEILVLLAGLLGNAKVSLASQSICLEIGGWH-LMIPGAFSAAVSTRVSNELGAGKP 321 (473)
T ss_pred hhhHHHHHHHhhcchheeHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHH-HHHhhhhhhhHHHHHHHHHcCCCh
Confidence 8899999999999999999999999999999999874 6888999998888864 677889999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHH
Q 018774 126 YMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA 204 (350)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 204 (350)
+++|.....+...++..++..+.. +...+.+...|..|+|+.+...+..++++...++...+.++.+..++.|..+...
T Consensus 322 ~~ar~~~~v~~~~~~~~g~~~~~~~~~~r~~~~~ift~~~ev~~~va~~~pll~~~~~~~~~q~v~~Gva~g~g~q~~ga 401 (473)
T KOG1347|consen 322 KRARVSAKVALQTSVAIGASLGTTLLACREVLGQIFTNSKEVLDLVADLTPLLALSILLNALQAVLSGVARGSGWQQIGA 401 (473)
T ss_pred hhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhccchhhhhheEEeeccccceE
Confidence 999999999999998888876555 6677888899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHH-HHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 205 WVSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 205 ~~~~~~~-~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
+.++... ++.+++...+-+..++|..|.|++...+..+..........+.
T Consensus 402 ~vnl~~yyl~G~p~g~~l~~~~~~g~~glw~G~~~~~~~~~~~l~~~~~~t 452 (473)
T KOG1347|consen 402 VINLVAYYLVGAPVGLYLGFFTKFGVKGLWIGILLGFSVQTLVLAIVTART 452 (473)
T ss_pred EEeeeeeeEecCcceeEEEEEEecCceEEEeehHHHHHHHHHHHHHheeec
Confidence 9998887 7777777777766789999999999999666666655554433
No 34
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=99.03 E-value=1.6e-06 Score=75.49 Aligned_cols=249 Identities=14% Similarity=0.080 Sum_probs=164.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCh---hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccch
Q 018774 49 IESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGD---LELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (350)
Q Consensus 49 ~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~---~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~ 125 (350)
..++.++++-+|+.++.+...+...+-+.-+++-.+ +.+|+|+++..+.-.+ ..+...+-+.... ++.+++
T Consensus 8 ~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~lf~-~sp~~~~~~igl~-----~V~s~r 81 (345)
T PF07260_consen 8 TSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLMLFF-ASPLSMFHHIGLV-----FVNSKR 81 (345)
T ss_pred chHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHHHH-hChhhhhHHHHHH-----Hhcchh
Confidence 468899999999999999999999988888887433 3589999999987664 4666666555443 333333
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HH-hhHHHH-HhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhH
Q 018774 126 YMLGVYMQRSWIVLFICCVLLLPL-YV-FASPVL-KLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMV 202 (350)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~-~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~ 202 (350)
+ -++.+......+.+......++ +- .+..++ ..++.++++.+.++..+.++.+--++.++...+.+++--.+++..
T Consensus 82 s-rr~~vl~~~vag~v~avi~~LIa~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILik~r~s~i 160 (345)
T PF07260_consen 82 S-RRKAVLCMAVAGAVAAVIHLLIAWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILIKHRHSWI 160 (345)
T ss_pred h-hHHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhhhccceeE
Confidence 3 2333333333333333332333 33 444444 567889999999999999999999999999999999987788888
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCCcc-chHH---HHHHHHHHHHHHHHHHHHHhc--CCCcccCCCChHhHHhHHHHHH
Q 018774 203 IAWVSLASLLVHLLVTWLFVYKMQLGL-IGTA---ITLSFSWWVLIFGMFGYVACG--GCPRTWTGFSMEAFSDLWEFVK 276 (350)
Q Consensus 203 ~~~~~~~~~~~~i~l~~~li~~~~~G~-~G~a---~a~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 276 (350)
....++...+..+++..+++.. ++.. .... ++...+..+........+++. +.+....+..+.+...++++++
T Consensus 161 V~~aSI~~v~~qvV~v~~ll~~-~l~~~~pllipil~~y~g~~vr~t~v~LGy~~~i~~~~p~~~~~~~~~~~tl~~~l~ 239 (345)
T PF07260_consen 161 VGSASIADVIAQVVLVAILLSM-HLEPQDPLLIPILALYAGIAVRFTIVCLGYYQSIHDIIPQLSGLEKGDSATLQRMLK 239 (345)
T ss_pred eehHHHHHHHHHHHHHHHHHcc-ccCccccHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhccccCCcccCCChhHHHHHH
Confidence 8777777766666655555532 1111 1111 222233322222222222222 3333333333445567899999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhc-CCCh
Q 018774 277 LSVASGVMLCLENWYYRVLILMTGN-LQNA 305 (350)
Q Consensus 277 ~~~p~~l~~~~~~~~~~~~~~~~~~-~g~~ 305 (350)
..+|.+........+--+.+.++++ +|.+
T Consensus 240 F~~PL~~~~~tq~~SrplVnl~vsR~l~gs 269 (345)
T PF07260_consen 240 FWWPLALVLATQRISRPLVNLFVSRDLSGS 269 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhccCCc
Confidence 9999999999999999999999999 5543
No 35
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=98.89 E-value=3e-07 Score=73.17 Aligned_cols=79 Identities=22% Similarity=0.244 Sum_probs=74.2
Q ss_pred HHHHHhHHHHHHHHHHHHHHHHHccchhHHHHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHh
Q 018774 174 SLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVAC 253 (350)
Q Consensus 174 l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~ 253 (350)
+++++++.++..+.....+.+++.||++..++.++++.++|+++++++++ ++|..|+++|+.+++.+......+..+|
T Consensus 2 l~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~~~v~i~~~~~li~--~~G~~Gaa~a~~i~~~~~~~~~~~~~~k 79 (146)
T PF14667_consen 2 LQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIGAIVNIILNYILIP--RFGIYGAAIATAISEIVSFILNLWYVRK 79 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHH--HHHHhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999999999999999999999999999999988 7999999999999999998888887776
Q ss_pred c
Q 018774 254 G 254 (350)
Q Consensus 254 ~ 254 (350)
+
T Consensus 80 ~ 80 (146)
T PF14667_consen 80 K 80 (146)
T ss_pred H
Confidence 6
No 36
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=98.72 E-value=4e-06 Score=80.67 Aligned_cols=203 Identities=8% Similarity=0.008 Sum_probs=160.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc--c-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccch--
Q 018774 51 SKKLWHIVGPTIFSRMASYSMFVITQAFAGH--L-GDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY-- 125 (350)
Q Consensus 51 ~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~--l-g~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~-- 125 (350)
-++.++++.....+++.-.+.+--|++++.. + ..++.|.|++++++-+++.=.+...+--..-...++....++.
T Consensus 252 d~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~~QGvY~lv~N~GSLvaR~lF~PiEEs~~~~Fsk~l~~~~~~~ 331 (549)
T PF04506_consen 252 DRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFEDQGVYALVSNYGSLVARLLFQPIEESSRLYFSKLLSRDNSKK 331 (549)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHHHhhHHHHHhhHHHHHHHHHhCcHHHHHHHHHHHHhcccCchh
Confidence 4678888999999999999999999999999 5 7789999999999999877778888888888888887655432
Q ss_pred -------hhHHHHHHHHHHHHHHHHHHHHH-HHHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHc
Q 018774 126 -------YMLGVYMQRSWIVLFICCVLLLP-LYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQ 197 (350)
Q Consensus 126 -------~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~ 197 (350)
++..+.....+.+...++++... +-..++.++.+++++......+...+++++..+|+.+++.+..++.++.
T Consensus 332 ~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~NGi~EaF~~s~ 411 (549)
T PF04506_consen 332 KQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAINGITEAFVFSV 411 (549)
T ss_pred hccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHccHHHHHHHHh
Confidence 34555666666666666665433 3556777777776554444456778999999999999999999999999
Q ss_pred cchhHHHHHHH---HHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 198 LKTMVIAWVSL---ASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 198 g~~~~~~~~~~---~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
...+.....+- +..++.+..++++... ++|..|..+|.++...+..+....++++.
T Consensus 412 a~~~~l~~~~~~m~~~S~~f~~~~~~l~~~-~~G~~GlI~AN~iNM~lRI~ys~~fI~~~ 470 (549)
T PF04506_consen 412 ASESQLDRYNYWMVVFSAIFLAASYLLTRW-GLGAVGLILANCINMSLRIIYSLRFIRRY 470 (549)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 88776654444 4446667788888875 69999999999999999998888887665
No 37
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=98.32 E-value=0.00063 Score=62.29 Aligned_cols=199 Identities=10% Similarity=0.051 Sum_probs=141.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhc---cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHhcccchhhHHH
Q 018774 54 LWHIVGPTIFSRMASYSMFVITQAFAGH---LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGV 130 (350)
Q Consensus 54 ~~~~~~p~~~~~~~~~~~~~vd~~~i~~---lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~~~ 130 (350)
..+...-...+.+.-.+.+-=|.+++.. +.-.+.|.|..++++-+++.-.+...+--......+|....++.|+.++
T Consensus 241 ~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~QgvYd~v~n~GSLlaR~iF~PIEEss~~~FA~~ls~~~qe~~k~ 320 (530)
T KOG2864|consen 241 LLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQGVYDLVSNYGSLLARLIFRPIEESSYIYFARLLSRDNQENVKK 320 (530)
T ss_pred HHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhhHHHHHHhhhhHHHHHHhChhHHHHHHHHHHHhhccchhhHHH
Confidence 3444444555666666677777777774 3555778888888887766677778888888888888887777776666
Q ss_pred HHHHH---HHHHHHHHHHHHH-HHHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHHH--
Q 018774 131 YMQRS---WIVLFICCVLLLP-LYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA-- 204 (350)
Q Consensus 131 ~~~~~---~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~-- 204 (350)
..... +.+...+|+..++ +...+...+.+.+++.-....+...++++|..+|+.+++.+..+++.+.+..+...
T Consensus 321 a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~YclYI~~lAiNGitEaF~~A~~t~~qi~~~ 400 (530)
T KOG2864|consen 321 AVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWYCLYIPFLAINGITEAFAFAVATSRQIDKH 400 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHHHHHHHHHHhccHHHHHHHHhccHHHHHhc
Confidence 55544 4444444433322 24456666677666554444556789999999999999999999999988776655
Q ss_pred -HHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 205 -WVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 205 -~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
+..++..++.++++|+++- .+|..|..+|.++...+..+....++++.
T Consensus 401 n~~mlafSviflilsylL~~--~~~~~GlIlANiiNm~lRIlys~~fI~~~ 449 (530)
T KOG2864|consen 401 NKFMLAFSVIFLILSYLLIR--WFGLVGLILANIINMSLRILYSLRFIRHY 449 (530)
T ss_pred ccchhHHHHHHHHHHHHHHH--HhchhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4455566778899999998 57889999999998887777766665544
No 38
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=97.72 E-value=0.0003 Score=61.65 Aligned_cols=72 Identities=19% Similarity=0.122 Sum_probs=66.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhH
Q 018774 47 FWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQA 119 (350)
Q Consensus 47 ~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~~ 119 (350)
+++..|++++.+.|..++++...+....|+.++++ .|++++|.|+.+.++.... ..+...+.+...|.+++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ii~~~~g~~~vg~Y~~a~~l~~~~-~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 200 SKKFFKEILRFGLPLFLSSLLSWLYSQIDRLIIGYFLGPEAVGIYSVAYRLASAI-SFLLSSISTVLFPRLSRL 272 (273)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHhCCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHh
Confidence 37899999999999999999999999999999999 6999999999999999985 678889999999999875
No 39
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=97.50 E-value=0.00011 Score=59.35 Aligned_cols=67 Identities=13% Similarity=-0.030 Sum_probs=61.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHhcCCChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhhhhcccCCC
Q 018774 280 ASGVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCLLLYTDIDF 348 (350)
Q Consensus 280 p~~l~~~~~~~~~~~~~~~~~~~g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~ 348 (350)
|.+++...+...+.+.+.+++++|+.+ ++++++..++..+..++..|+++|.++++++.++.+|.|.
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g~~~--~a~~~i~~~~~~~~~~~~~g~~~a~~~~~s~~~G~~~~~~ 67 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLGPEA--LAAYGIASSIFSILFMLIFGLATALQILISQNIGAGDYKR 67 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCTTCC--CCHCCHHHHHHHHHHHHHHHHHHHHHHHHCCCCCSSSTTT
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhCHHH--HHHHHHHHHHHHHHhhhcccccccccceeecccccccccc
Confidence 889999999999999999999998755 5599999999999999999999999999999999888764
No 40
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=96.81 E-value=0.012 Score=50.88 Aligned_cols=66 Identities=18% Similarity=0.140 Sum_probs=60.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHh
Q 018774 53 KLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQ 118 (350)
Q Consensus 53 ~~~~~~~p~~~~~~~~~~~~~vd~~~i~~-lg~~~~a~~~~a~~l~~~~~~~~~~g~~~a~~~~~s~ 118 (350)
+.++.+.|...+++.....+.+|.++++. +|++++|.|+.+.++.......+..++++...|.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~~~g~y~~a~~l~~~~~~~~~~~i~~~~~p~lar 250 (251)
T PF13440_consen 184 RLLKYGLPFSLSSLLSWLLSQIDRLLIGYFLGPEAVGIYSVAQRLASLPASLLSSAISSVFFPKLAR 250 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhC
Confidence 37999999999999999999999999999 8999999999999999865337899999999998886
No 41
>COG4267 Predicted membrane protein [Function unknown]
Probab=94.59 E-value=3.5 Score=37.60 Aligned_cols=141 Identities=13% Similarity=0.162 Sum_probs=94.6
Q ss_pred HHHHHHHHHHHHhHHHHHHhHhcccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHhcCCCHHHHHHHHHHHHHHH
Q 018774 99 AFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLL 178 (350)
Q Consensus 99 ~~~~~~~~g~~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 178 (350)
.+..++..|+....+..+|...=++|++++...+.-...+....+..+... +-....+... .|=...+
T Consensus 71 ifS~IiTgg~q~iiTRfiSD~lF~k~~~kIlpsy~Gvi~lv~~~a~~ig~~-------vf~~~~~~si-----~yk~l~~ 138 (467)
T COG4267 71 IFSQIITGGFQLIITRFISDCLFEKKQRKILPSYIGVILLVTLVAGVIGLI-------VFFVNNQYSI-----VYKILAC 138 (467)
T ss_pred HHHHHHhhhHHHHHHHHHHHHHHHHHHHHHhHhHHHHHHHHHHHHHHHHHH-------hhhhcCchhH-----HHHHHHH
Confidence 334566777777778888887777777777766655554444443332211 1111222211 1223334
Q ss_pred hHHHHHHHHHHHHHHHHHccchhHHHHHHHHHHHHHHHHHHHHHhhcCCccchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 179 PVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 179 ~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~G~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
.....+...-....++.+.+|.+...+.-.++.++.+.+..++-. +++.|.-++..++..+.......+..|.
T Consensus 139 ~~FV~m~~~Wi~~iFlS~lK~y~~iv~sF~iG~~~sv~La~~~~~---~~ie~lLL~~~IGi~~i~~l~~~~Ilr~ 211 (467)
T COG4267 139 ALFVGMSLVWILMIFLSGLKKYKLIVLSFFIGYVVSVLLARLFLK---SPIEGLLLTLDIGIFIILFLLNFYILRY 211 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hHHHHHHHHHHHhHHHHHHHHHHHHHHh
Confidence 445555666677888999999999999999999998888887764 6999999999999988777776666655
No 42
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=92.22 E-value=12 Score=36.56 Aligned_cols=74 Identities=8% Similarity=-0.114 Sum_probs=53.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc--CCChhhHHHHHHHHHHHHHHHH-HHhhHhhhhHhhhhhhhhhccc
Q 018774 271 LWEFVKLSVASGVMLCLENWYYRVLILMTGN--LQNAKIAVDALSICMSINGWES-QICYYSISGDLDCNWCLLLYTD 345 (350)
Q Consensus 271 ~~~~~~~~~p~~l~~~~~~~~~~~~~~~~~~--~g~~~~~vaa~~i~~~~~~~~~-~~~~~~~~a~~~~~~~~~~~~~ 345 (350)
-++.++.......+.....+..+-...++.. +.+.+ +-+.|.+++|+.+++. .+..-+=.+.-...++....++
T Consensus 252 d~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~-~QGvY~lv~N~GSLvaR~lF~PiEEs~~~~Fsk~l~~~~ 328 (549)
T PF04506_consen 252 DRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFE-DQGVYALVSNYGSLVARLLFQPIEESSRLYFSKLLSRDN 328 (549)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHH-HhhHHHHHhhHHHHHHHHHhCcHHHHHHHHHHHHhcccC
Confidence 4678888888888888899888888888887 54422 3458999999988876 3345566666666666665543
No 43
>COG4267 Predicted membrane protein [Function unknown]
Probab=72.35 E-value=82 Score=29.17 Aligned_cols=95 Identities=8% Similarity=0.030 Sum_probs=51.5
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHhcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHccchhHH
Q 018774 125 YYMLGVYMQRSWIVLFICCVLLL-PLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVI 203 (350)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~ 203 (350)
.+++....++.+.-.+-+-...+ .++..++.+..+++.++...+ .+++-.++.-.......+-...-=.++.+..
T Consensus 319 ~~kMiltlrq~i~~~~~lQ~~a~l~~flL~~~Ll~~~~lS~~~l~----lF~vd~lg~s~~i~f~~ll~i~lyfd~r~i~ 394 (467)
T COG4267 319 LKKMILTLRQGILEIMELQMLASLLCFLLADALLLWFGLSEYYLD----LFYVDVLGVSCQIVFMSLLNIFLYFDYRRIA 394 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 34444455555544444443333 345578888888776553332 3344444433332222222222224555667
Q ss_pred HHHHHHHHHHHHHHHHHHHh
Q 018774 204 AWVSLASLLVHLLVTWLFVY 223 (350)
Q Consensus 204 ~~~~~~~~~~~i~l~~~li~ 223 (350)
+..+.+-.+.|.++++++..
T Consensus 395 l~~t~~fli~N~ilT~i~l~ 414 (467)
T COG4267 395 LELTALFLISNGILTFIFLE 414 (467)
T ss_pred hhhhhHHHHHhHHHHHHHHH
Confidence 77777777889888888875
No 44
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=63.83 E-value=41 Score=30.29 Aligned_cols=73 Identities=4% Similarity=0.015 Sum_probs=60.5
Q ss_pred HHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CChhhHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhh
Q 018774 268 FSDLWEFVKLSVASGVMLCLENWYYRVLILMTGNL-QNAKIAVDALSICMSINGWESQICYYSISGDLDCNWCL 340 (350)
Q Consensus 268 ~~~~~~~~~~~~p~~l~~~~~~~~~~~~~~~~~~~-g~~~~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~ 340 (350)
...++++++.-+|.+++.....+.-.+.+.-+++- .+....+|+|+++..+.-++..+...+-+....++...
T Consensus 7 ~~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~lf~~sp~~~~~~igl~~V~s~ 80 (345)
T PF07260_consen 7 LTSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLMLFFASPLSMFHHIGLVFVNSK 80 (345)
T ss_pred cchHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHHHHhChhhhhHHHHHHHhcch
Confidence 45678899999999999998888888888888874 44334478999999999999999988888888887764
No 45
>KOG2234 consensus Predicted UDP-galactose transporter [Carbohydrate transport and metabolism]
Probab=47.16 E-value=2.1e+02 Score=26.12 Aligned_cols=47 Identities=13% Similarity=0.041 Sum_probs=26.6
Q ss_pred HHHHHHHHHHHHHHHHhc-CC--CcccCCCChHhHHhHHHHHHHHHHHHH
Q 018774 237 SFSWWVLIFGMFGYVACG-GC--PRTWTGFSMEAFSDLWEFVKLSVASGV 283 (350)
Q Consensus 237 ~i~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~p~~l 283 (350)
.+++++-.++....+.++ +. ++..+..++.-+...++.+|.++|.++
T Consensus 52 ~~~Ei~Kl~~c~~~~~~~~~~~~~~~~~~l~~~i~~~~~~~lk~~vPa~i 101 (345)
T KOG2234|consen 52 FLTEVIKLVFCLFLLLFEERKYAKKSLKSLSKEILAAPRETLKVSVPALI 101 (345)
T ss_pred HHHHHHHHHHHHHHHHHHhhHHhhhhhhhcCHHHHhChHHHHHHHHHHHH
Confidence 344444444444444333 11 222233455566777899999999886
No 46
>PF03904 DUF334: Domain of unknown function (DUF334); InterPro: IPR005602 This is a family of proteins found in Staphylococcus aureus plasmid with no characterised function.
Probab=42.97 E-value=1.4e+02 Score=25.30 Aligned_cols=38 Identities=16% Similarity=0.197 Sum_probs=22.2
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHhcC
Q 018774 124 KYYMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLG 161 (350)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 161 (350)
+++...+.+..++...+++.+++++++.++.++..+++
T Consensus 142 ~y~k~~k~~~~gi~aml~Vf~LF~lvmt~g~d~m~fl~ 179 (230)
T PF03904_consen 142 KYQKRQKSMYKGIGAMLFVFMLFALVMTIGSDFMDFLH 179 (230)
T ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHhcccchhhhh
Confidence 45555555555555555555555556666667666665
No 47
>PF02487 CLN3: CLN3 protein; InterPro: IPR003492 Batten's disease, the juvenile variant of neuronal ceroid lipofuscionosis (NCL), is a recessively inherited disorder affecting children of 5-10 years of age. The disease is characterised by progressive loss of vision, seizures and psychomotor disturbances. Biochemically, the disease is characterised by lysosomal accumulation of hydrophobic material, mainly ATP synthase subunit C, largely in the brain but also in other tissues. The disease is fatal within a decade []. Mutations in the CLN3 gene are believed to cause Batten's disease []. The CLN3 gene, with a predicted 438-residue product, maps to chromosome p16p12.1. The gene contains at least 15 exons spanning 15kb and is highly conserved in mammals []. A 1.02kb deletion in the CLN3 gene, occurring in either one or both alleles, is found in 85% of Batten disease chromosomes causing a frameshift generating a predicted translated product of 181 amino acid residues [, ]. 22 other mutations, including deletions, insertions and point mutations, have been reported. It has been suggested that such mutations result in severely truncated CLN3 proteins, or affect its structure/conformation [, ]. CLN3 proteins, which are believed to associate in complexes, are heavily glycosylated lysosomal membrane proteins [], containing complex Asn-linked oligosaccharides []. Extensive glycosylation is important for the stability of these lysosomal proteins in the highly hydrolytic lysosomal lumen. Lysosomal sequestration of active lysosomal enzymes, transport of degraded molecules from the lysosomes, and fusion and fission between lysosomes and other organelles. The CLN3 protein is a 43kDa, highly hydrophobic, multi-transmembrane (TM), phosphorylated protein []. Hydrophobicity analysis predicts 6-9 TM segments, suggesting that CLN3 is a TM protein that may function as a chaperone or signal transducer. The majority of putative phosphorylation sites are found in the N-terminal domain, encompassing 150 residues []. Phosphorylation is believed to be important for membrane compartment interaction, in the formation of functional complexes, and in regulation and interactions with other proteins []. CLN3 contains several motifs that may undergo lipid post-translational modifications (PTMs). PTMs contribute to targeting and anchoring of modified proteins to distinct biological membranes []. There are three general classes of lipid modification: N-terminal myristoylation, C-terminal prenylation, and palmitoylation of cysteine residues. Such modifications are believed to be a common form of PTM occurring in 0.5% of all cellular proteins, including brain tissue []. The C terminus of the CLN3 contains various lipid modification sites: C435, target for prenylation; G419, target for myristoylation; and C414, target for palmitoylation []. Prenylation results in protein hydrophobicity, influences interaction with upstream regulatory proteins and downstream effectors, facilitates protein-protein interaction (multisubunit assembly) and promotes anchoring to membrane lipids. The prenylation motif, Cys-A-A-X, is highly conserved within CLN3 protein sequences of different species []. Species with known CLN3 protein homologues include: Homo sapiens, Canis familiaris, Mus musculus, Saccharomyces cerevisiae and Drosophila melanogaster.; GO: 0016020 membrane
Probab=40.36 E-value=1.1e+02 Score=28.80 Aligned_cols=30 Identities=17% Similarity=0.087 Sum_probs=23.1
Q ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 018774 43 LTRRFWIESKKLWHIVGPTIFSRMASYSMF 72 (350)
Q Consensus 43 ~~~~~~~~~k~~~~~~~p~~~~~~~~~~~~ 72 (350)
.++...+..|.++++-+|+.+..+.+.+.+
T Consensus 234 ~~~~k~~~~k~Ll~ymiPL~lVY~aEY~In 263 (402)
T PF02487_consen 234 SFKEKLKRLKPLLWYMIPLFLVYFAEYFIN 263 (402)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 344566778888889999998888887653
No 48
>KOG3097 consensus Predicted membrane protein [Function unknown]
Probab=39.11 E-value=3.1e+02 Score=25.26 Aligned_cols=63 Identities=11% Similarity=0.073 Sum_probs=42.9
Q ss_pred CCcccccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHH
Q 018774 37 DDSAGTLTRRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVA 99 (350)
Q Consensus 37 ~~~~~~~~~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~~lg~~~~a~~~~a~~l~~~ 99 (350)
+++++++.+..+...|++.-.+.-.++......-.....+..-..+|+..+++...+.....+
T Consensus 14 ~~~~~~~~r~~~~~~knv~i~s~~fl~~f~a~~gl~nlq~~vn~~lg~~sl~~~y~~l~~s~m 76 (390)
T KOG3097|consen 14 EEEERRYRRKRLGILKNVLILSIAFLLTFTAYLGLQNLQTSVNYDLGTVSLGALYLSLIDSSM 76 (390)
T ss_pred CcccchhcccccchhhhhhHHHHHHHHHHHHHHHHHHHHHHHhcCcccchhhhhhHHHHHHHH
Confidence 333444445566788888888888888777776666666666556888888877766555444
No 49
>PRK03612 spermidine synthase; Provisional
Probab=37.48 E-value=4e+02 Score=26.02 Aligned_cols=27 Identities=15% Similarity=0.160 Sum_probs=17.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHhc-cChhH
Q 018774 60 PTIFSRMASYSMFVITQAFAGH-LGDLE 86 (350)
Q Consensus 60 p~~~~~~~~~~~~~vd~~~i~~-lg~~~ 86 (350)
-.+++.+...++..+-..+++. +|...
T Consensus 22 ~~f~sg~~~L~yEv~~~r~l~~~~G~s~ 49 (521)
T PRK03612 22 AVFVCAACGLVYELLLGTLASYLLGDSV 49 (521)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhCchH
Confidence 3445667777777777777776 56543
No 50
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=32.04 E-value=4.7e+02 Score=25.16 Aligned_cols=47 Identities=6% Similarity=0.038 Sum_probs=28.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHHHHHhccChhHHHHHHHHHHHHH
Q 018774 52 KKLWHIVGPTIFSRMASYSMFV-ITQAFAGHLGDLELAAISIANTVVV 98 (350)
Q Consensus 52 k~~~~~~~p~~~~~~~~~~~~~-vd~~~i~~lg~~~~a~~~~a~~l~~ 98 (350)
..-.+-+.-.+..++...+.++ ++.+.+-+++++.+|..++=..+..
T Consensus 8 ~ss~~ga~~~i~~Q~~~RiiTF~lN~~liR~~s~~v~gi~nvrl~lL~ 55 (530)
T KOG2864|consen 8 ESSFSGAVFSIRGQLLARIITFALNALLIRFLSPEVLGIVNVRLELLQ 55 (530)
T ss_pred HHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHcChhheehhHHHHHHHH
Confidence 3344444555555555555555 4555555589999888877666554
No 51
>PF05313 Pox_P21: Poxvirus P21 membrane protein; InterPro: IPR007977 The p21 membrane protein of vaccinia virus, encoded by the A17L (or A18L) gene, has been reported to localise on the inner of the two membranes of the intracellular mature virus (IMV). It has also been shown that p21 acts as a membrane anchor for the externally located fusion protein P14 (A27L gene) [].; GO: 0016021 integral to membrane
Probab=29.79 E-value=2.2e+02 Score=23.27 Aligned_cols=26 Identities=15% Similarity=0.142 Sum_probs=18.3
Q ss_pred cchHHHHHHHHHHHHHHHHHHHHHhc
Q 018774 229 LIGTAITLSFSWWVLIFGMFGYVACG 254 (350)
Q Consensus 229 ~~G~a~a~~i~~~~~~~~~~~~~~~~ 254 (350)
+.|-..++.+++.+..++..++.++.
T Consensus 136 ~s~s~~~~ti~yIiL~iLf~~Ya~nl 161 (189)
T PF05313_consen 136 VSGSSGAYTISYIILAILFCIYAFNL 161 (189)
T ss_pred hhHhHHHHHHHHHHHHHHHHHheeec
Confidence 34666777888888777777776655
No 52
>TIGR00155 pqiA_fam integral membrane protein, PqiA family. This family consists of uncharacterized predicted integral membrane proteins found, so far, only in the Proteobacteria. Of two members in E. coli, one is induced by paraquat and is designated PqiA, paraquat-inducible protein A.
Probab=29.16 E-value=4.9e+02 Score=24.49 Aligned_cols=81 Identities=14% Similarity=0.043 Sum_probs=46.8
Q ss_pred CCCCCCCCCCccCccccCCCCCccccccCCCCCCCCCCcccccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 018774 1 MPSNGKKEGTNVPLLQDSASTNVPLLQGSASTAPSPDDSAGTLTRRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAG 80 (350)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~p~~~~~~~~~~~~~vd~~~i~ 80 (350)
|||+++++-......=+.=..-..+.+-...+...+.++.....+.......+.+.+++-..+-.+..+.+.++..-..|
T Consensus 1 ~~~~~~~~~~~~~~~C~~Cd~l~~~~~l~~g~~a~CpRCg~~L~~~~~~~~~~~lAl~italil~i~An~~P~~~~~~~G 80 (403)
T TIGR00155 1 MPKMCEHHPAAKHILCSQCDMLVALPRIESGQKAACPRCGTTLTVGWDWSLQRPAAYALAALFLMPFSNLFPLLNMNLLG 80 (403)
T ss_pred CccccccCCCCCeeeCCCCCCcccccCCCCCCeeECCCCCCCCcCCCCCCHHHHHHHHHHHHHHHHHHHhChHHhheecC
Confidence 89999844444322111111111111223444566777766666666666777788888777777777777777666555
Q ss_pred c
Q 018774 81 H 81 (350)
Q Consensus 81 ~ 81 (350)
.
T Consensus 81 ~ 81 (403)
T TIGR00155 81 I 81 (403)
T ss_pred C
Confidence 4
No 53
>KOG0054 consensus Multidrug resistance-associated protein/mitoxantrone resistance protein, ABC superfamily [Secondary metabolites biosynthesis, transport and catabolism]
Probab=28.87 E-value=8.6e+02 Score=27.20 Aligned_cols=34 Identities=6% Similarity=-0.344 Sum_probs=25.3
Q ss_pred hHHHHHHHHHHHHHHHHHHhhHhhhhHhhhhhhh
Q 018774 307 IAVDALSICMSINGWESQICYYSISGDLDCNWCL 340 (350)
Q Consensus 307 ~~vaa~~i~~~~~~~~~~~~~~~~~a~~~~~~~~ 340 (350)
.+..+-++.+.+...+.++|.++++..++.|+--
T Consensus 458 ~aF~slalfniLr~pl~~~P~~i~~~vqa~VS~~ 491 (1381)
T KOG0054|consen 458 TAFTSLALFNILRFPLFMLPSVISQLVQAKVSLK 491 (1381)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3444566666777778889999999999887753
No 54
>COG4304 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=28.61 E-value=17 Score=28.04 Aligned_cols=9 Identities=44% Similarity=1.331 Sum_probs=6.8
Q ss_pred hcccCCCCC
Q 018774 342 LYTDIDFPQ 350 (350)
Q Consensus 342 ~~~~~~~~~ 350 (350)
-|.||||||
T Consensus 112 iYaDFdYPe 120 (166)
T COG4304 112 IYADFDYPE 120 (166)
T ss_pred HHHhcCChH
Confidence 467888886
No 55
>PF04505 Dispanin: Interferon-induced transmembrane protein; InterPro: IPR007593 This family includes the human leukocyte antigen CD225, which is an interferon inducible transmembrane protein, and is associated with interferon induced cell growth suppression [].; GO: 0009607 response to biotic stimulus, 0016021 integral to membrane
Probab=23.64 E-value=2.6e+02 Score=19.46 Aligned_cols=32 Identities=6% Similarity=0.030 Sum_probs=24.2
Q ss_pred HHHHhHhcccchhhHHHHHHHHHHHHHHHHHH
Q 018774 114 TLCGQAFGGKKYYMLGVYMQRSWIVLFICCVL 145 (350)
Q Consensus 114 ~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~ 145 (350)
..+-..+.+||++++++.-+++..++.+..+.
T Consensus 42 ~kv~~~~~~Gd~~~A~~aS~~Ak~~~~ia~~~ 73 (82)
T PF04505_consen 42 SKVRSRYAAGDYEGARRASRKAKKWSIIAIII 73 (82)
T ss_pred hhhHHHHHCCCHHHHHHHHHHhHHHHHHHHHH
Confidence 44566777899999999998888877655444
No 56
>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.
Probab=23.49 E-value=1.2e+02 Score=23.13 Aligned_cols=11 Identities=18% Similarity=0.154 Sum_probs=4.5
Q ss_pred chHHHHHHHHH
Q 018774 230 IGTAITLSFSW 240 (350)
Q Consensus 230 ~G~a~a~~i~~ 240 (350)
.|+.++..++-
T Consensus 67 ~~Ii~gv~aGv 77 (122)
T PF01102_consen 67 IGIIFGVMAGV 77 (122)
T ss_dssp HHHHHHHHHHH
T ss_pred eehhHHHHHHH
Confidence 33444444443
No 57
>PF05975 EcsB: Bacterial ABC transporter protein EcsB; InterPro: IPR010288 ABC transporters belong to the ATP-Binding Cassette (ABC) superfamily, which uses the hydrolysis of ATP to energise diverse biological systems. ABC transporters minimally consist of two conserved regions: a highly conserved ATP binding cassette (ABC) and a less conserved transmembrane domain (TMD). These can be found on the same protein or on two different ones. Most ABC transporters function as a dimer and therefore are constituted of four domains, two ABC modules and two TMDs. ABC transporters are involved in the export or import of a wide variety of substrates ranging from small ions to macromolecules. The major function of ABC import systems is to provide essential nutrients to bacteria. They are found only in prokaryotes and their four constitutive domains are usually encoded by independent polypeptides (two ABC proteins and two TMD proteins). Prokaryotic importers require additional extracytoplasmic binding proteins (one or more per systems) for function. In contrast, export systems are involved in the extrusion of noxious substances, the export of extracellular toxins and the targeting of membrane components. They are found in all living organisms and in general the TMD is fused to the ABC module in a variety of combinations. Some eukaryotic exporters encode the four domains on the same polypeptide chain []. The ABC module (approximately two hundred amino acid residues) is known to bind and hydrolyse ATP, thereby coupling transport to ATP hydrolysis in a large number of biological processes. The cassette is duplicated in several subfamilies. Its primary sequence is highly conserved, displaying a typical phosphate-binding loop: Walker A, and a magnesium binding site: Walker B. Besides these two regions, three other conserved motifs are present in the ABC cassette: the switch region which contains a histidine loop, postulated to polarise the attaching water molecule for hydrolysis, the signature conserved motif (LSGGQ) specific to the ABC transporter, and the Q-motif (between Walker A and the signature), which interacts with the gamma phosphate through a water bond. The Walker A, Walker B, Q-loop and switch region form the nucleotide binding site [, , ]. The 3D structure of a monomeric ABC module adopts a stubby L-shape with two distinct arms. ArmI (mainly beta-strand) contains Walker A and Walker B. The important residues for ATP hydrolysis and/or binding are located in the P-loop. The ATP-binding pocket is located at the extremity of armI. The perpendicular armII contains mostly the alpha helical subdomain with the signature motif. It only seems to be required for structural integrity of the ABC module. ArmII is in direct contact with the TMD. The hinge between armI and armII contains both the histidine loop and the Q-loop, making contact with the gamma phosphate of the ATP molecule. ATP hydrolysis leads to a conformational change that could facilitate ADP release. In the dimer the two ABC cassettes contact each other through hydrophobic interactions at the antiparallel beta-sheet of armI by a two-fold axis [, , , , , ]. The ATP-Binding Cassette (ABC) superfamily forms one of the largest of all protein families with a diversity of physiological functions []. Several studies have shown that there is a correlation between the functional characterisation and the phylogenetic classification of the ABC cassette [, ]. More than 50 subfamilies have been described based on a phylogenetic and functional classification [, , ]; (for further information see http://www.tcdb.org/tcdb/index.php?tc=3.A.1). This family consists of several bacterial ABC transporter proteins which are homologous to the EcsB protein of Bacillus subtilis. EcsB is thought to encode a hydrophobic protein with six membrane-spanning helices in a pattern found in other hydrophobic components of ABC transporters [].
Probab=22.41 E-value=6.3e+02 Score=23.45 Aligned_cols=35 Identities=20% Similarity=0.358 Sum_probs=25.9
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHH
Q 018774 124 KYYMLGVYMQRSWIVLFICCVLLL-PLYVFASPVLK 158 (350)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~ 158 (350)
++++.+++.+++...+.+...... ++....-|+..
T Consensus 89 ~e~~~~~y~~~a~~yS~~~~~~~~~~~~~ll~Pl~~ 124 (386)
T PF05975_consen 89 KESEMKQYFKRALRYSFVLQLLIQLLVFLLLLPLLM 124 (386)
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 457899999999999998887654 44555556654
No 58
>TIGR00927 2A1904 K+-dependent Na+/Ca+ exchanger.
Probab=22.06 E-value=1.9e+02 Score=30.41 Aligned_cols=33 Identities=6% Similarity=-0.199 Sum_probs=14.5
Q ss_pred HHHHhHhcccchhhHHHHHHHHHHHHHHHHHHH
Q 018774 114 TLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLL 146 (350)
Q Consensus 114 ~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~ 146 (350)
..++...|.+|..-...+-...+.+.+.++++.
T Consensus 987 SvivArkG~gdMAVan~iGSNIFnIllgLGlPW 1019 (1096)
T TIGR00927 987 SVIVARKGLGDMAVSSSVGSNIFDITVGLPVPW 1019 (1096)
T ss_pred HHHHHHccCCcceeeeccccchheeeeeccHHH
Confidence 333334455554444333344444444445543
No 59
>PF01914 MarC: MarC family integral membrane protein; InterPro: IPR002771 Members of this family are integral membrane proteins that includes the antibiotic resistance protein MarC. These proteins may be transporters. ; GO: 0016021 integral to membrane
Probab=21.30 E-value=4.9e+02 Score=21.73 Aligned_cols=63 Identities=13% Similarity=0.143 Sum_probs=38.4
Q ss_pred HHHHHHHHhHHHHHHhHhcccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHhcCCCHHHHHHH
Q 018774 103 GLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELS 170 (350)
Q Consensus 103 ~~~~g~~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (350)
.+...++.. |.....-+..+.++.|+..++.....+++.+ +..++++.+++.|+-+-+..+.+
T Consensus 13 ~iinP~g~i--p~f~~lt~~~~~~~r~~ia~~a~~~a~~ill---~f~~~G~~iL~~fgIsl~af~Ia 75 (203)
T PF01914_consen 13 AIINPIGNI--PIFLSLTKGMSPKERRRIARRASIIAFIILL---IFAFFGQLILNFFGISLPAFRIA 75 (203)
T ss_pred HHHhHHHHH--HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHhCCCHHHHHHH
Confidence 344555544 5555555555666777777766555544433 34556888999998876655443
No 60
>PF02592 DUF165: Uncharacterized ACR, YhhQ family COG1738; InterPro: IPR003744 This is a family of uncharacterised proteins. Conserved regions of hydrophobicity suggest that all members of the family may be integral membrane proteins.
Probab=20.63 E-value=4.2e+02 Score=20.66 Aligned_cols=58 Identities=5% Similarity=-0.046 Sum_probs=28.3
Q ss_pred cchHHHHHHHHHHHHHHHHHHHHHhcCCCcccCCCChHhHHhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 018774 229 LIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENWYYRVLI 296 (350)
Q Consensus 229 ~~G~a~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~l~~~~~~~~~~~~~ 296 (350)
.....+|..++.+++-....+.+.+-|.+ +++ +. -.++......+.+..+...+....
T Consensus 67 ~~ri~~aS~~a~lisq~~d~~if~~lk~~--~~~-----r~---lw~R~~~St~isq~iDt~if~~ia 124 (145)
T PF02592_consen 67 TPRIALASLIAFLISQLLDVYIFSKLKRK--TKG-----RS---LWLRNNGSTAISQLIDTVIFITIA 124 (145)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHh--cCC-----cc---HHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34455566666666555554444322111 110 01 124555666677777776665533
Done!